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The research in this dissertation focuses on the analysis of time to event data.
Chapter 2 considers weighted proportional hazards models in the presence of biased
sampling and estimated selection probabilities. Chapter 3 examines the degree of bias
corrected by the method proposed in Chapter 2 and proposes a method for evaluating
the performance of the model. Chapter 4 considers the study of recurrent events in
the presence of a terminating event. The proposed procedures involve modelling the
recurrent event rate and terminal event hazard sparately; then combining the models
to estimate the treatment effect on the recurrent event mean.
In biomedical studies, investigators often encounter data which are a potentially
biased (i.e., unrepresentative) sample of the target population. Of particular interest
is the two-stage sampling set-up. In the first stage, a representative sample of the tar-
get population is obtained with complete information on certain auxiliary variables.
In the second stage, a biased sample is selected from the representative sample and
the outcome (e.g., failure time) variable is missing for unselected subjects. Because
of the partially missing outcome, it is not possible to fit a model (e.g., a proportional
hazards model) to the representative sample and make unbiased inferences appli-
cable to the target population. The possibility for biased sampling makes fitting
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an unweighted proportional hazards model to the subjects with complete informa-
tion (complete-case analysis) potentially problematic. The estimated effect of the
covariate of interest would be biased if there exist variables which play the role of
“biasing factor”, where the term “biasing factor” refers to a variable correlated with
the covariate of interest which affects the failure time hazard and the second stage
selection probability. The observed relationship between the outcome and the factor
of interest among subjects selected at the second stage is systematically different
from that in the target population, since the effect of the biasing factor (not being
accounted for in the estimation procedure) on the outcome is partially reflected.
A general method for overcoming selection bias involves weighting each subject by
the inverse of their second-stage selection probability. This procedure was developed
by Horvitz and Thompson (1952) to estimate a population mean. Binder (1992)
extended the Horvitz-Thompson estimator for application to proportional hazards
models. The data structure of interest in the proposal by Binder (1992) has only
one selection step (from the target population to the biased sample) with known
selection probabilities; a very reasonable framework for survey studies or designed
experiments. After weighting each subject by the inverse of their selection probability
(pi), each subject in the observed sample represents 1/pi identical subjects in the
target population. As such, one can write out an appropriate partial likelihood and
corresponding score function which would apply to the target population.
Lin (2000) extended the one-step sampling framework in Binder’s paper (1992)
to two-stage sampling, in the sense that a representative sample was added between
the target population and the biased sample. The underlying target population
was assumed by Lin (2000) to be infinite. The selection probabilities at the second
stage were still assumed to be known. The weighted score equations in Lin (2000)
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had the same form as those in Binder (1992), and hence the regression coefficient
estimators were also the same. The difference in the estimator of Lin (2000) was that
additional variation was induced by the sampling step from the target population to
the representative sample. Correspondingly, the variance estimator proposed by Lin
(2000) had one extra component relative to that of Binder (1992) which accounted
for the extra variation introduced by the first-stage sampling mechanism.
Both Binder (1992) and Lin (2000) assumed that the selection probabilities for
each subject were known and hence could be treated as fixed. In observational
studies, it is common to encounter data structures with two-stage sampling and
unknown selection probabilities. That is, one observes the auxiliary information
for the representative sample and the complete information for the biased sample
without any foreknowledge of the selection probabilities. This data structure is the
subject of the weighted proportional hazards model in Chapter 2.
For two-stage sample data with unknown selection probabilities, we propose two-
stage methods to obtain appropriate parameter and variance estimates. In the first
stage, a logistic model is fitted to estimate the selection probability from the repre-
sentative sample to the biased sample, adjusting for auxiliary variables (assumed to
represent the biasing factors). At the second stage, a weighted proportional hazards
model is fitted using the inverse of the estimated selection probabilities as weights.
Under the assumption of consistent selection probability estimators, the regression
parameter and cumulative baseline hazard estimators are consistent for their respec-
tive true underlying values and hence converge to the same limiting values as their
predecessors with fixed weights. However, the proposed variance estimators are dif-
ferent from those of either Binder (1992) or Lin (2000) since the weights themselves
have variation. Large-sample properties of the proposed parameter estimators are de-
4
rived and their applicability to finite samples is examined through simulation studies.
The proposed methods are then applied to a kidney transplant data set to estimate
the effects of expanded criteria donor (ECD) kidneys on the post-transplant graft
failure hazard. The increase in the hazard for patients receiving an ECD (relative
to non-ECD) kidney is found to be greatly underestimated in the existing literature
which has used the information from the transplanted ECD organs only.
There exist methods in the current literature which are related to those proposed
in Chapter 2, such as inverse-probability-of-treatment-weighting (IPTW) (Robins,
2000; Hernan et al., 2000; Hernan et al., 2001), and propensity scoring (Rosenbaum
and Rubin, 1983; Rosenbaum, 2002). These methods are either infeasible for our
real data setup or answer questions different from those of interest, as we describe
later in some detail.
In applying the method proposed in Chapter 2, a practical question to be answered
is whether or not the second stage sampling mechanism actually does generate bias.
The effect of interest has two true underlying values; one describing the relationship
between the factor under study and the outcome in the target population, the other
describing the corresponding relationship in a hypothetical population represented
by the potentially biased sample selected in the second sampling stage. These two
underlying parameters would be different if and only if biasing factors exist. The
same can be said of the baseline hazard. To identify cases where the two parame-
ters differ and an empirically weighted proportional hazards model is necessary, two
conceptually simple yet comprehensive tests are proposed in Chapter 3. For the re-
gression parameter and cumulative baseline hazard, test statistics are constructed as
the difference of the weighted estimates proposed in Chapter 2 and their unweighted
counterparts. The asymptotic distributions of each of the test statistics is derived
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and explicit variance estimators are proposed. The empirical significance level and
power are validated through simulation. Factors affecting the power are examined.
It is observed that as long as the size of the second stage sample is not too small (e.g.,
n ≥ 20), the achieved power is generally quite high. A similar test for the baseline
hazard function is proposed. Finally, both tests are applied to another renal failure
data set, from which we seek to draw inference for the wait-listed patients (target
population) and only observe transplanted patients (potential biased sample) with
hospitalization history serving as the assumed potential biasing factor.
In Chapter 4, we study recurrent events in the presence of a terminating event.
Several approaches to the analysis of recurrent event data exist in literature. If
the cumulative number of events are of interest, one can model the recurrent event
rate/mean; the rate being the derivative of mean function (e.g., Pepe and Cai, 1993;
Lawless and Nadeau, 1995; Lin, Wei, Yang and Ying, 2000). If the instantaneous
event occurrence probability given the event history is of interest, an intensity model
can be employed (e.g., Prentice et al., 1981; Andersen and Gill, 1982; Wei et al.,
1989; Lee et al., 1992). Depending on the form of covariate effects, the recurrent
event model can be either multiplicative or additive (e.g., Schaubel, Zeng and Cai,
2006).
Another characteristic of the data structure of interest is the coexistence of a
terminating event which is also affected by the treatment and adjustment covari-
ates. Commonly applied methods to handle the terminating event either model the
marginal number of the recurrent events averaging over living and deceased subjects
(e.g., Ghosh and Lin, 2000; Ghosh and Lin, 2002) or model the conditional recurrent
event rate given survival (e.g., Cook and Lawless, 1997; Lin et al., 2000). Both types
of methods have their own limitations. For the marginal method, the occurrence of
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more recurrent events in a treatment group could result from longer survival or a
higher recurrent event rate while subjects are alive, and it is difficult to differentiate
the two possible causes. For the conditional method, the cumulative treatment ef-
fects over time cannot be estimated by integrating the instantaneous rate over time,
since the integral is only interpretable in the unrealistic setting where subjects never
die.
We propose fitting a proportional hazards model for the terminating event and an
additive model for the recurrent event rate conditional on survival separately, then
integrating over time to estimate the cumulative recurrent event means. In this way,
the treatment effect is measured through a time varying process without assuming
a functional form for the treatment effect. Two measures are proposed along these
lines. The first compares the treatment effect on the recurrent events and factors
out differences in survival distributions between the groups. In order to isolate the
treatment effect on the recurrent events, a hypothetical scenario is considered in
which treatment-specific survival is equal. The second incorporates the potentially
distinct survival distributions in treatment groups and reflects the mean difference
in treatment-specific marginal recurrent event means, again computed by combining
the survival probability and the conditional recurrent event rate.
Asymptotic properties of the estimators for both measures are derived and eval-
uated in finite samples. In addition, these methods are found to perform reasonably
well under misspecified models. Finally the proposed methods are applied to kidney
transplantation data to study the difference between ECD and non-ECD transplan-
tation with respect to the cumulative number of post-transplant hospitalizations. In
spite of the fact that ECD recipients die significantly earlier, they experience signifi-




Proportional Hazards Models Based on Biased Samples and
Estimated Selection Probabilities
Abstract: In non-randomized biomedical studies using the proportional hazards
model, the observed data often constitute a biased (i.e., unrepresentative) sample
of the underlying target population, resulting in biased regression coefficients. The
bias can be avoided by weighting included subjects by the inverse of their respective
selection probabilities, as proposed by Horvitz & Thompson (1952) and extended to
the proportional hazards setting for use in surveys by Binder (1992) and Lin (2000).
The weights can be treated as fixed in cases where they are known (e.g., chosen by
the investigator) or based on voluminous data (e.g., a large-scale survey). However,
in many practical applications, the weights are estimated and must be treated as
such in order for the resulting inference to be accurate. We propose a two-stage
weighted proportional hazards model in which, at the first stage, weights are esti-
mated through a logistic regression model fitted to a representative sample from the
target population. At the second stage, a weighted Cox model is fitted to the biased
sample. We propose estimators for the regression parameter and cumulative baseline
hazard. Asymptotic properties of the parameter estimators are derived, accounting
for the difference in the variance introduced by the randomness of the weights. The
accuracy of the asymptotic approximations in finite samples is evaluated through
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simulation. Our method is illustrated in an analysis of renal transplant patients
using data obtained from the Scientific Registry of Transplant Recipients (SRTR).
Key words and phrases: Hazard regression; observational studies; selection bias;
survival analysis; weighted Cox model.
2.1 Introduction
Often in observational studies, the study population observed is a biased sample
of the target population. For example, if the importance of a certain characteris-
tic is of interest (e.g., diabetes), then the true effect of being diabetic (relative to
non-diabetic) in the target population may be greatly understated by a regression
model based on the study sample if the diabetics entered into the study are system-
atically healthier than those in the target population (i.e., in ways unmeasured by
the remaining model covariates). We propose a method for estimating the param-
eters in the Cox proportional hazards model (Cox 1972), for settings in which the
survival model is fitted to a biased sample. Unlike existing weighted versions of the
Cox model (Binder 1992; Lin 2000), the proposed method uses weights which are
estimated and treated as such in deriving the asymptotic properties of the parameter
estimators.
Our proposed method is motivated by the study of the use of “expanded criteria
donor” (ECD) organs by end-stage renal disease patients. Kidney transplantation
is the preferred method of renal replacement therapy (the alternative being dialy-
sis) in terms of patient survival (Schaubel et al. 1995; Wolfe et al. 1999). With
the increasing demand for donor organs, kidneys from ECDs are increasingly being
considered for patients on the wait-list, even though it has been demonstrated that
ECD organs are associated with a significantly increased risk of graft failure (Port et
10
al. 2002), which is usually defined as the minimum of time of death and time when
the transplanted organ ceases to function.
Our objective is to accurately estimate the magnitude of the increase in the graft
failure hazard for ECD relative to non-ECD deceased-donor kidneys. Although the
fact that ECD kidneys have an increased risk of graft failure can already be concluded
based on previous reports (e.g., Port et al. 2002), the true magnitude of the increase
requires further investigation. It is necessary that an accurate estimate of the relative
hazard of graft failure of ECD organs be available. Because this estimate is targeted
to provide information for clinicians and wait-listed patients facing the choice of ac-
cepting or rejecting a procured kidney, inference should be based on the hypothetical
scenario where all procured kidneys (ECD or non-ECD) are transplanted. A Cox
model fitted to the post-transplant population is likely to underestimate the true
average ECD effect, since organs in the transplanted population represent a biased
sample of all the donor kidneys available for transplantation. Kidneys from younger
healthier ECDs have a higher chance of being transplanted, and donor’s health con-
ditions have a direct influence on the graft failure hazard. If we compare the survival
function of the “best” ECD kidneys to that of “average” non-ECD kidneys without
adjusting for selection bias, the negative effects of ECD organs on survival will be
attenuated. In reality, there will also be selection of non-ECD organs. But, it is
likely that a much greater fraction of ECD organs are discarded, reflecting a greater
degree of selection from the ECD organ pool.
A natural idea to generate consistent estimators of population parameters in
the presence of biased samples is to weight each subject by the reciprocal of their
probability of being sampled. In the context of the transplant data, subjects re-
fer to kidneys and selection probability refers to the probability of the organ be-
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ing transplanted, as opposed to discarded. Horvitz & Thompson (1952) proposed
such a method to provide an unbiased estimate of a population mean. The use
of inverse-probability-of-selection weighting was extended to the Cox proportional
hazards model by Binder (1992), then Lin (2000) and Boudreau & Lawless (2006).
Binder (1992) developed his method primarily for use in survey sampling, with the
weights being chosen by the investigator. Thus, the partial likelihood score equation
used weights based on inclusion probabilities which were treated as fixed, which is
reasonable when the sampling scheme is known or information of the whole target
population is collected (e.g., United States census). Lin (2000) further studied the
case when the biased sample is selected from a representative sample of the tar-
get population, resulting in extra variation in the parameter estimates. Boudreau
& Lawless (2006) proposed stratified proportional hazards models that account for
the fact that the data have been collected according to a complex survey design.
In many practical settings, inclusion probabilities are not known and must be esti-
mated empirically by auxiliary information from the representative sample. If the
weights are estimated consistently and treated as fixed, the Cox model parameter
estimates are still consistent. However, not accounting for the fact that the weights
are trained by the data leads to variance estimators which overestimate the true
variability, resulting in conservative confidence intervals and significance levels.
In this article, we propose a two-stage procedure for fitting a weighted proportional
hazards model. At the first stage, selection probabilities are estimated from a logistic
regression model applied to both selected and unselected subjects. The inverse of the
estimated selection probabilities are used as weights. At the second stage, a weighted
Cox model is fitted, with the randomness in the weight estimates accounted for in the
proposed inference procedures. In the causal inference literature, inverse-probability-
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of-treatment weighting (IPTW) (Robins 2000; Hernan, Brumback & Robins 2000;
Hernan, Brumback & Robins 2001) and pair-matching or stratification by propensity
scores (Rosenbaum & Rubin 1983; Rosenbaum 2002) are widely used methods for
biased samples. Differences between IPTW, propensity scoring and the proposed
method are explained in Section 2.
The remainder of this article is organized as follows. In Section 2, we describe the
proposed estimation procedure and its connection to existing methods. In Section 3,
the asymptotic properties of our parameter estimators are provided. In Section 4, the
applicability of the asymptotic properties in finite samples is evaluated by numerical
studies. In Section 5, the proposed method is applied to data from a national organ
failure registry. In Section 6, a discussion and some concluding remarks are provided.
Proofs of the main results listed in Section 3 are outlined in the Appendix.
2.2 Models And Methods
We begin by establishing the necessary notation. For subject i (i = 1, . . . , N) with
event time Ti and censoring time Ci, we define T̃i = min(Ti, Ci), ∆i = I(Ti≤Ci),
Yi(t) = I(T̃i≥t) and Ni(t) = I(T̃i≤t, ∆i = 1). There are a total of N subjects in the
representative sample, with a biased study sample of size n < N .
In analyzing time to event data, proportional hazards are often assumed, such
that the hazard function at time t for subject i with p × 1 covariate vector Zi(t) is
proportional to the baseline hazard function at time t,
λi(t) = λ0(t)e
β′0Zi(t),
where β0 is the true value of the regression parameter vector and the true baseline
hazard function λ0(t) is unspecified. Ordinarily, one would estimate β0 by β̂, the
13






{Zi(t)− Z(β, t)}dNi(t) = 0,(2.1)
where dNi(t) = Ni(t + dt) − Ni(t), τ is a prespecified constant satisfying Pr(T̃i >















Under mild conditions, Andersen & Gill (1982) proved that n1/2(β̂ − β0) converges
asymptotically to a zero-mean Gaussian process with covariance consistently esti-
mated by Â(β̂)−1 where Â(β̂) = −n−1∂U(β)/∂β|β=β̂.
In instances where subjects may have unequal probability of being sampled,
Binder (1992) & Lin (2000) proposed the weighted proportional hazards model. The






wi{Zi(t)− Zw(β, t)} dNi(t),(2.2)






















Lin (2000) proved that the solution to (3.4) is also asymptotically zero-mean
normal with an explicit covariance matrix expression. Both Binder (1992) and Lin
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(2000) studied the case when the weights are known and hence their estimating
functions have the same form. Binder’s method can be used when the biased study
sample is selected directly from the target population with fixed probabilities; Lin’s
proposal further studied the settings where the biased study sample is selected from a
representative sample of the underlying target population, with the target population
being considered infinite and referred to as a super-population. The difference lies
in the asymptotic variance of the parameter estimators. The proposed variance
estimator in Lin (2000) is larger than that proposed by Binder (1992), owing to the
additional variation attributable to the random selection of the representative sample
from the target population.
In existing weighted Cox models, wi is assumed known and treated as fixed. There
are many practical settings where inclusion probability is not known and must be
estimated empirically. We propose a two-stage method wherein the probabilities used
in the weighted Cox model are estimated from a logistic regression model based on
both selected and unselected subjects. Our proposed method uses the same setting as
in Lin (2000), but with selection probabilities that are not fixed and are empirically












and Xi is the vector of covariates in the logistic regression model. Ideally, Xi is the
complete set of biasing factors. By biasing factors, we refer to factors predictive
of selection probability and survival time and correlate with the factor of interests.
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In the case of unmeasured biasing factors, consistent estimators of θ0 and hence β0
are unobtainable. The robustness of our estimators to unmeasured confounders is
examined through simulation in Section 4. Note that internal covariates governing
both pi and λi(t) would be included in both Xi and Zi. When the Zi covariate is
time-dependent (i.e., Zi(t)6=Zi(0)), it would make sense that Zi(0) be included in Xi,
but not Zi(t) for t > 0, since selection into the biased sample is determined at t = 0.






ULi(θ) = Xi{Ii − pi(θ)}.
Having estimated θ0, β0 is estimated by β̂w, the solution to U
w






wi(θ){Zi(t)− Zw(β, θ, t)} dNi(t).
Having computed β̂w, the cumulative hazard function Λ0(t) can be consistently esti-
mated by Λ̂w0 (β̂w, θ̂; t) where









w (β, θ; s)
.
We describe the asymptotic properties of the proposed parameter estimators in the
next section.
The proposed method is built around inverse probability of selection weighting
(IPSW), an idea related to but distinct from inverse probability of treatment weight-
ing (IPTW) (Robins & Greenland 1994; Robins, Greenland & Hu 1999; Robins 2000).
To avoid confusion, it is worth clarifying some of the differences between IPSW and
IPTW, and in doing so we restrict attention to the setting of interest; i.e., data
to estimate selection probability are available from a super-population. In IPSW,
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subjects are weighted by the inverse of their respective selection probabilities, which
is the transplantation probability per kidney in the motivating example. In IPTW,
subjects are weighted by the inverse of the probability they received their assigned
treatment, which would be probability of receiving an ECD kidney per recipient. The
purpose of IPSW is to mimic the composition of the representative sample, while the
IPTW method aims to obtain an unconfounded comparison between the treatments.
In IPSW, the logistic model uses information from all subjects in the representative
sample. In IPTW, the logistic model would be fitted to only the biased sample. Note
also that a logistic model would suffice for IPTW when the covariate of interest was
binary. However, it would appear that estimation of the weight would become cum-
bersome if the treatment covariate was continuous or, even worse, multi-dimensional.
In contrast, the IPSW weight is easily estimated, whether the weights are intended
to correct bias with respect to a single covariate (e.g., ECD) or several (e.g., ECD,
age, gender, race, diagnosis, etc).
It is also worth noting that, for the application of our interest in the current
study, IPTW does not apply and does not even make sense in principle. For the
kidney transplant data, the representative sample contains all kidneys recovered in
1999 − 2003, while the biased sample consists of kidneys which are actually trans-
planted. The factor of interest is ECD status, while selection probability represents
the probability that a recovered kidney is transplanted. For an IPTW analysis,
one would estimate the probability of a transplanted organ being its actual sta-
tus (ECD or non-ECD) given all donor characteristics, including those in the ECD
definition. As such, in attempting to apply IPTW, one would weight subjects by
Pr(Ei = z|Xi)−1, where Ei is a binary indicator for ECD status and z is a realiza-
tion of Ei. Since Xi contains the components of the ECD definition, Pr(Ei = z|Xi)
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always equals 0 or 1.
The IPSW method is also related to but different from methods based on propen-
sity scores (Rosenbaum & Rubin 1983; Rosenbaum 2002), as the latter involves
scores constructed from the probability of being assigned the treatment (as opposed
to placebo), given all confounders used for pair-matching or stratification.
2.3 Asymptotic Properties
In this section, we describe the large-sample properties of the model parameter es-
timators. Proof sketches are provided in the Appendix. Note that since wi(θ) will
contain elements not in the filtration pertaining to the assumed Cox model, the Mar-
tingale Central Limit Theorem (Fleming & Harrington 1991; Kalbfleisch & Prentice
2002) is not applicable here. We assume the following regularity conditions:
(a) {Ti, Ci, Zi, Xi} are independent and identically distributed for i = 1, . . . , N .




dΛ0(t) < ∞ and Λ0(t) is differentiable over time.
(d) |Xik| < ∞; |Zik(0)| +
∫ τ
0
|Zik(s)|ds < ∞ almost surely, where the second sub-
script refers to the kth element.
(e) Positive-definiteness of the matrices, Aw(β, θ) and B(θ), where
Aw(β, θ) = E
[∫ τ
0
{Zi(t)− zw(β, θ; t)}⊗2wi(θ)Yi(t)eβ′Zi(t)dΛ0(t)
]
,
s(1)w (β, θ; t) = lim
N→∞
S(1)w (β, θ; t),
s(0)w (β, θ; t) = lim
N→∞
S(0)w (β, θ; t),
zw(β, θ; t) =
s
(1)
w (β, θ; t)
s
(0)
w (β, θ; t)
,
B(θ) = E[Xipi(θ){1− pi(θ)}X ′i]
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with a⊗2 = aa′.
(f) There exists a δ such that pi(θ) > δ > 0 almost surely.
Condition (a) is employed in the application of the Functional Central Limit The-
orem (Pollard 1990). Provided that the subjects are independent, the assumption
applies quite generally. Independence would be violated if, for example, subjects
are clustered by some factor related to the failure time of interest. Condition (b)
is a standard identifiability requirement. Condition (c) leads to the boundedness of
several quantities examined in the proofs of the theorems stated later in this section.
The bounded covariate condition, (d), is not required but simplifies proofs of the
asymptotic results and is applicable in most practical situations. Assumption (e)
essentially requires that there are no linear dependencies among the covariates in
either the survival or selection probability models. With respect to condition (f),
selection probability is non-zero for all subjects of interest in the underlying target
population, by definition. This condition guarantees that N and n go to ∞ at the
same rate, such that
√
n/N converges to a constant.
The proposed methods also assume implicitly that Zi ∪Xi consists of all factors
affecting λi(t); that is, the no-unmeasured confounders assumption. In addition, we









Pr(t ≤ Ti < t + δ|Ti ≥ t, Zi, Xi).
Theorem 1. Under conditions (a) to (f), β̂w converges almost surely to β0.
The proof of Theorem 1 is outlined in the Appendix. It proceeds through a Taylor
Series expansion, repeated application of the Strong Law of Large Numbers (SLLN),
followed by arguments from convex function theory.
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Theorem 2. Under conditions (a) to (f), N
1
2 (β̂w − β0) is asymptotically zero-mean
normal with covariance matrix Aw(β0, θ0)
−1Σw(β0, θ0)Aw(β0, θ0)−1 as N →∞, where
Aw(β0, θ0) is as defined in condition (e),
Σw(β, θ) = E{ψwi (β, θ)⊗2},
ψwi (β, θ) =
∫ τ
0
wi(θ){Zi(t)− zw(β, θ; t)}dMi(t)−G(β, θ)B(θ)−1ULi,
G(β, θ) = E
[∫ τ
0
{Zi(t)− zw(β, θ; t)}X ′ie−θ
′XidMi(β; t)
]
with dMi(β; t) = dNi(t)− Yi(t)eβ′ZidΛ0(t).
The matrix Σw(β0, θ0) can be consistently estimated by replacing β0, θ0 and all
expectations by their empirical estimates; that is,










dM̂i(β, θ; t) = dNi(t)− Yi(t)eβ′ZidΛ̂w0 (β, θ; t),













Similarly, the matrix Aw(β0, θ0) can be consistently estimated by Â
w(β̂w, θ̂), where





{Zi(t)− Zw(β, θ; t)}⊗2wi(θ)Yi(t)eβ′Zi(t)dΛ̂w0 (β, θ; t).(2.3)
Therefore, the covariance matrix for N
1






. The asymptotic distribution of β̂w can be derived
by combining the Multivariate Central Limit Theorem (van der Vaart 2000) and
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results from empirical process theory (Pollard 1990; Wellner 1996; Bilias, Gu & Ying
1997).
If the weights are treated as fixed, the variance estimator differs from the proposed
one with respect to the ψwi component. Under the setting of designed sampling over
the target population with fixed selection probability, the variance estimator also has
the sandwich form,
Âw(β̂w, θ̂)
−1Σ̂f (β̂w, θ̂)Âw(β̂w, θ̂)−1,(2.4)
where Âw(β̂w, θ̂) is the same as that defined in (2.3) and




wi(θ){Zi(t)− zw(β, θ; t)}dMi(t).
We summarize the essential asymptotic results for the baseline cumulative hazard
estimator in the following two theorems.
Theorem 3. Under conditions (a) to (f), Λ̂w0 (β̂w, θ̂; t) converges uniformly to Λ0(t)
for t ∈ [0, τ ].
The proof of Theorem 3 involves decomposing {Λ̂w0 (β̂w, θ̂; t)−Λ0(t)} into {Λ̂w0 (β̂w, θ̂; t)−
Λ̂w0 (β̂w, θ0; t)}, {Λ̂w0 (β̂w, θ0; t)−Λ̂w0 (β0, θ0; t)} and {Λ̂w0 (β0, θ0; t)−Λ0(t)}, then applying
the Uniform SLLN and various empirical process results.
Theorem 4. Under conditions (a) to (f), N
1
2{Λ̂w0 (β̂w, θ̂; t)−Λ0(t)} converges weakly
to a zero-mean Gaussian process with covariance function:
Ω(s, t) = E{φi(β0, θ0; s)φi(β0, θ0; t)},
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for (s, t) ∈ [0, τ ]× [0, τ ], where φi(β, θ; t) = φi1(β, θ; t)+φi2(β, θ; t)+φi3(β, θ; t), with
b(β, θ; t) = E{Xie−θ′XiYi(t)eβ′Zi(t)},


















φi1(β, θ; t) = k
′(β, θ; t)B(θ)−1ULi(θ),




φi2(β, θ; t) = h
′(β, θ; t)Aw(β, θ)−1ψwi (β, θ),






w (β, θ; s)
.
The proof involves applications of the Central Limit Theorem and empirical pro-
cess results. The quantity Ω(s, t) can be consistently estimated by replacing all
unknown quantities by their empirical counterparts.
2.4 Simulation Study
In our simulation settings, there are three covariates, with Zi = (Zi1, Zi2, Zi3)
′. The
covariate Zi1 is distributed as Bernoulli with equal probabilities of being 1 or 0;
Zi2 is normally distributed with mean zero and variance 25; Zi3 is uniformly dis-
tributed on (0, 4). Time to event, Ti, follows an exponential distribution with hazard
λi(t) = λ0e
β′0Zi , where λ0 = 0.02, and β
′
0 = (β1, β2, β3) = (0.5, 0.1, 1.0). The cen-
soring time, Ci, was generated as uniform on (0, 20) or (0, 40) to create data sets
with different percentages of censoring (denoted by C%); specifically 20% and 30%.
We create representative samples with three different sizes (500, 1000 or 5000) and
biased samples are created by selecting different percentages of subjects in each
Zi1 and Zi3 combination. Specifically, subjects with Zi1 = 0 are always included
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in the biased sample; for subjects with Zi1 = 1, probability of being included in
the biased sample depends on Zi3 with selection probability being constant across
[0, 1], (1, 2], (2, 3], (3, 4]. Each data configuration is replicated 1000 times.
Of primary interest are the marginal effects of Zi1 and Zi2, while Zi3 represents
a variable that affects λi(t) but is not incorporated in the Cox model. Hence the
Cox model fitted to each replicate is λi(t) = λ0(t)e
β1Zi1+β2Zi2 . The weights were
based on the logistic model, log{pi(θ)/(1− pi(θ))} = θ′Xi, where Xi = (Zi1, Zi3)′. It
is worth noting that very few failure time distributions (e.g. positive stable frailty)
have proportional hazards for both the conditional and the marginal models. In cases
where the proportional hazards assumption does not hold perfectly, the β1 estimate
can be understood as a time-weighted average Zi1 effect; albeit with weights for which
no explicit form exists and which depend on the censoring distribution (Struthers &
Kalbfleisch, 1986).
Although in the representative sample Zi3 is independent of Zi1, in the biased
sample Zi3 distributes differently for Zi1 = 0 and Zi1 = 1. Therefore, the marginal
effects of Zi1 over Zi3 in the representative sample and in the biased sample are un-
equal. Thus, in the biased sample, omitting biasing factor Zi3 from the Cox model
results in biased estimator of β1 if we use an unweighted Cox model. The true β1 is
determined empirically by applying proportional hazards model to the representative
sample. Take the following data configuration as an example: selection probability
on the four increasing levels of Zi3 are 1, 0.5, 0.4 and 0.1, and the parameter esti-
mates from the representative sample is (β1, β2)
′ = (0.318, 0.064)′. Note that there
are two sets of true parameters for the representative sample here; the conditional
regression coefficients (β1, β2, β3)
′ = (0.5, 0.1, 1.0)′ and the marginal regression coeffi-
cients (β1, β2)
′ = (0.318, 0.064)′. Because our goal is to estimate the marginal effect,
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Pr(Ii = 1|Z1i = 1, Z3i) β̂1w
C%1 β̂1 wi(θ̂): fixed 2 wi(θ̂): estimated 3
N [0, 1] (1, 2] (2, 3] (3, 4] Bias Bias ESD ASE CP ASE CP
30 250 1.000 0.500 0.400 0.100 -0.47 -0.03 0.20 0.22 0.95 0.18 0.92
500 1.000 0.500 0.400 0.100 -0.47 -0.00 0.14 0.16 0.97 0.13 0.94
500 1.000 0.750 0.500 0.250 -0.34 -0.01 0.12 0.13 0.98 0.12 0.94
500 0.500 0.500 0.500 0.500 -0.00 -0.00 0.13 0.14 0.97 0.13 0.94
1000 0.500 0.250 0.200 0.050 -0.47 -0.01 0.11 0.14 0.99 0.11 0.94
5000 0.100 0.050 0.040 0.010 -0.47 -0.01 0.10 0.14 0.99 0.09 0.93
5000 0.200 0.100 0.075 0.025 -0.47 -0.01 0.07 0.09 1.00 0.07 0.95
20 250 1.000 0.500 0.400 0.100 -0.43 -0.03 0.18 0.19 0.96 0.16 0.93
500 1.000 0.500 0.400 0.100 -0.42 -0.01 0.11 0.14 0.98 0.11 0.95
500 1.000 0.750 0.500 0.250 -0.30 -0.01 0.11 0.12 0.95 0.11 0.95
500 0.500 0.500 0.500 0.500 -0.00 -0.00 0.12 0.13 0.96 0.12 0.95
1000 0.500 0.250 0.200 0.050 -0.42 -0.01 0.10 0.13 0.99 0.09 0.94
5000 0.100 0.050 0.040 0.010 -0.42 -0.01 0.08 0.12 0.99 0.08 0.94
5000 0.200 0.100 0.075 0.025 -0.42 -0.01 0.06 0.08 0.99 0.06 0.94
1 C% = Ê(I(Ci < Ti)) .
2 wi(θ̂): fixed : variance estimator which treats weights as fixed, as given in equation (2.4).
3 wi(θ̂): estimated : proposed variance estimator, which treats the weights as estimated and is
derived in Theorem 1.
Table 2.1: Simulation Results:Weighted and Unweighted Proportional Hazards Model.
(0.318, 0.064)′ are the target population parameters of interest. If we fit a propor-
tional hazards model to the selected sample without any weight adjustment, serious
bias is observed; the empirical mean of β̂1 across the 1, 000 replicates computed as
Ê(β̂1) = −0.152. Note that β̂2 is still approximately unbiased, with Ê(β̂2) = 0.067,
since Zi2 is not correlated with Zi3 and therefore not affected by the omission of Zi3
from the fitted Cox model.
Simulation results are listed in Table 1. For each data configuration, the bias of
the unweighted and weighted β1 estimates (denoted by β̂1 and β̂w1, respectively) are
compared. We also list side by side the average asymptotic standard error (ASE) for
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two different variance estimators; the first variance estimator treats the weights as
fixed and is given by (2.4), while the second is the proposed variance estimator based
on Theorem 1. In addition, both ASEs are compared to the empirical standard devi-
ation (ESD). The comparison between the two variance estimators is also made with
respect to empirical coverage probability (CP), which has nominal level 0.95. From
Table 1, the unweighted β1 estimates are obviously biased, while the corresponding
weighted estimates are approximately unbiased. Treating the weights as fixed leads
to over-estimation of SE(β̂w1), with coverage probability being considerably larger
than 95%. The proposed SE estimator is on average much closer to the ESD and
correspondingly has empirical coverage probability more closely approximating the
nominal 0.95.
Rather than increasing the variation of β̂w, our proposed variance estimator ac-
tually has smaller variance than the variance estimator which treats the weights as
fixed. The decrease in the variance can be understood heuristically by the fact that
the weights are “trained” by the data, since subjects used to fit the weighted Cox
model are also used to estimate θ0. In row 6 − 9, this difference in ASE and CP
remains the same with sample sizes increasing from 500 to 5000.
We also examined the setting where the selection probabilities and, hence, weights
were in fact known. In this case, with the weights appropriately treated as fixed in
estimating the variance, the β1 estimator is approximately unbiased, but with ESD
considerably larger than that of β̂w1 (data not tabulated).
Next, we examine the impact of misspecification of the selection probability model.
The overall criteria for model performance is to minimize the sum of bias square and
variance; that is, mean square error (MSE). The simulation results listed in Ta-
ble 1 are generated using a correct logistic model which includes all covariates that
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influence the selection probability, with each covariate modelled using its correct
functional form. Additional simulations aimed at assessing the MSE of our estima-
tor disclose that both bias and variance of β̂w increases with the degree to which
the selection probability model is misspecified. In the most extreme case of model
misspecification when the logistic model contains no covariates (i.e., an intercept-
only model), β̂w and ŜE(β̂w) equal those from the unweighted model. The impact
of misspecifying the selection probability model is exemplified in Table 2. In the
last row of Table 2, the correct selection probability model is fitted. Other rows
feature various degrees of model misspecification, with the misspecification generally
increasing from bottom to top. Comparing the ASEs computed using Theorem 1 to
the ESD, the proposed SE estimator agrees with the empirical SE even when the
selection probability model is misspecified. The more accurate the selection proba-
bility model, the smaller the bias and the greater the efficiency gain associated with
the proposed variance estimator relative to that which treats the weights as fixed.
2.5 Application
Of interest is the impact of Expanded Criteria Donor (ECD) kidneys on the graft
failure hazard for renal transplant recipients. The time of graft failure is defined as
the time between transplantation and the earliest of the time of death and the time
at which the transplanted kidney ceases to function. By the definition of Port et
al. (2002), ECDs are either (i) age ≥ 60, or (ii) age 50 − 59 and with at least two
of the following three characteristics: hypertensive, serum creatinine concentration
> 1.5mg/dl, or death due to stroke. To the nephrology community, ECD is a well-
accepted quality index for donated kidneys. In fact, patients who are willing to accept
an ECD organ are essentially placed on a separate waiting list. It is well-known that
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Bias ASE
Covariates in Logistic Model β̂1 β̂1w wi(θ̂): fixed 4 wi(θ̂): estimated 5 ESD
various incorrect models:
no covariates −0.427 −0.427 0.101 0.101 0.100
categorical Z3 −0.423 −0.429 0.099 0.099 0.098
Z1 −0.427 −0.429 0.103 0.103 0.105
Z1, linear Z3 −0.423 −0.040 0.103 0.079 0.080
Z1, categorical Z3 −0.427 −0.015 0.120 0.077 0.081
correct model:
Z1, categorical Z3, interaction −0.428 −0.014 0.120 0.077 0.080
of categorical Z3 and Z1
4 wi(θ̂): fixed : variance estimator which treats weights as fixed, as given in equation (2.4).
5 wi(θ̂): estimated : proposed variance estimator, which treats the weights as estimated and is
derived in Theorem 1.
Table 2.2: Impact of selection probability model misspecification on bias and efficiency of proposed
variance estimator.
ECD kidneys have higher risk of graft failure or death. However, we hypothesize that
the magnitude of the increase is considerably greater than that currently reported
in the nephrology literature. Suppose that among the ECD kidneys procured, only
the “healthiest” are selected for transplantation (the remainder discarded). Suppose
also that the same sort of selection process occurs for non-ECD organs, but to a
much lesser extent. If we fit an unweighted model using transplanted kidneys only,
we would be comparing the healthiest ECD kidneys with a closer-to-representative
sample of non-ECD kidneys, and the negative impact of ECD on graft survival would
therefore be underestimated. In order to remove the effect of the biased sampling,
we apply the proposed weighted proportional hazards model. The covariate vector
includes terms for recipients (age, gender, race, years on ESRD and diabetic status)
and donor ECD status. Note that adjusting for the ECD components in the Cox
model is undesirable since the ECD parameter of interest cannot be identified in the
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presence of such adjustment.
Our treatment of the time axis warrants some discussion. First, since the time
origin is the time of transplant, all patients begin observation at t = 0, such that
left truncation does not occur. Second, there is the issue of length-biased sampling,
discussed by Wang (1999). That is, patients with longer time survived on the wait-
list would be over-represented in the data set. However, as previously indicated,
“time on dialysis prior to transplant” is an element of Zi. Finally, on a related
note, induced dependent censoring potentially resulting from correlation between
waitlist-to-transplant and transplant-to-death gap times (Schaubel & Cai 2004) is
also mitigated; i.e., the second gap time is, essentially, modelled as a function of the
first gap time.
The target population is all kidneys from deceased donors in U.S.. The repre-
sentative sample consists of all such kidneys with initial referral calls to their Organ
Procurement Organization (OPO) made during the 1999 to 2003 period. Demo-
graphic and clinical data on donors and recipients, dates of graft failure and death
where applicable, as well as various clinical measures, are obtained from the Scientific
Registry of Transplant Recipients (SRTR) and collected by the Organ Procurement
and Transplant Network (OPTN). Kidneys transplanted to recipients under age 18
are excluded. Each recipient was followed until graft failure, loss to follow up or
the conclusion of the observation period (December 31, 2004). In total, there were
57,213 donors with complete information. Of the 12, 673 ECD kidneys, 5, 830 (46%)
got transplanted. In contrast, of the 44, 540 non-ECD kidneys procured, 37, 227
(84%) were transplanted. Altogether 43, 057 (75%) out of the procured kidneys
got transplanted. Among the 43, 057 transplantations, 4, 452 had missing informa-
tion (transplantation date unknown), 29, 640 recipients were alive with a functioning
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transplant at the end of follow-up, and 8, 965 (23%) experienced graft failure (i.e.,
either died or had a transplant that stopped functioning) before the end of 2004.
Since the SRTR data include complete information of both transplanted and dis-
carded kidneys, we fit a logistic model to estimate each procured kidney’s trans-
plantation probability, adjusting for donor characteristics, including: demographics
(gender, age, race), cause of death (stroke, anoxia, tumor, others), lifestyle habits
(alcohol, smoking, cocaine, other drug), disease history (cancer, diabetes, hyperten-
sion), serology results (hepatitis B antibody, hepatitis C antibody, cytomegalovirus
antibody), cardiovascular disease, high creatinine level, blood urea nitrogen, presence
of protein in urine, clinical infection, and having tattoos. Among these variables,
donor age, hypertension history, high creatinine level, and stroke as cause of death
are used in the ECD definition. The weight assigned to each recipient is the inverse
of the estimated probability that their respective organ was transplanted as opposed
to discarded.
Selected parameters from the selection probability model are listed in Table 3.
All ECD-related variables have significant effects on the probability of being selected
for transplantation. The model appears to fit fairly well in a general sense, as the
proportion of concordant outcomes (C-statistic) equals 82%.
Comparison of the weighted and unweighted ECD coefficient estimates and dif-
ferent estimators for the standard error from the weighted Cox model is made in
Table 4. We observe a great difference between the unweighted and weighted ECD
coefficient estimates, with β̂ = 0.54 versus β̂w = 0.79. We can interpret these results
as follows: among the kidneys transplanted, patients getting an ECD kidney have
e0.54 = 1.72 times higher hazards for graft failure compared to patients getting a
non-ECD kidney; while among all the kidneys recovered for transplantation, ECD
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k Xik θ̂k ŜE(θ̂k) p eθ̂k
1 High creatinine -1.17 0.04 < 0.0001 0.31
2 Hypertension -0.47 0.03 < 0.0001 0.62
3 Cause of death = stroke -0.18 0.03 < 0.0001 0.84
4 Age 60 - 64 -0.58 0.06 < 0.0001 0.56
5 Age 65 - 69 -1.19 0.06 < 0.0001 0.31
6 Age ≥ 70 -2.59 0.07 < 0.0001 0.08
Table 2.3: Estimated regression parameter for ECD-related characteristics.
Quantity Estimate Formula Comment
β̂ 0.54 solution to (3.3) unweighted parameter estimator
eβ̂ 1.72 unweighted hazard ratio
β̂w 0.79 solution to (3.4) weighted parameter estimator
eβ̂w 2.20 weighted hazard ratio
ŜE 0.152 equation (2.4) treating wi(θ̂) as known
ŜE 0.149 Theorem 1 treating wi(θ̂) as estimated
p < 0.0001 based on proposed method
Table 2.4: Analysis of kidney transplant data estimated regression parameter and standard error
for ECD covariate.
status is associated with a e0.79 = 2.20 times higher graft failure hazard. If we treat
the weights as fixed, the estimator for the standard error of the ECD element of β̂w
is 0.152. Using the proposed variance estimator, the standard error is estimated at
0.149. In this example, whether we treat the weights either as fixed or as estimated,
the ECD indicator is highly significant (p < 0.0001). However, it is easy to envision
other cases where the overestimated SE leads to a deceptively large p value, a wider
confidence interval and perhaps a type I error.
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2.6 Discussion
Building on the weighted proportional hazards models proposed by Binder (1982),
Lin (2000) and Boudreau & Lawless (2006), this paper examines the setting where
weights are estimated from the data and thus should be treated as such for the
purposes of inference. The estimating equations for the parameter estimators are
similar to those of existing weighted Cox models, but the variance estimators have
a different form. We prove the consistency and derive the asymptotic distribution
of the proposed regression parameters and cumulative baseline hazard estimator.
Through simulation, the asymptotic results were found to be applicable to finite
samples. Finally, the proposed method was applied to a national kidney transplant
data set to evaluate the effect of expanded criteria donor organs on graft survival.
The proposed method depends on the availability of additional information of the
representative sample from which the biased sample is selected. If one can obtain
only the information on a biased sample, the probability of being selected into the
biased sample cannot be estimated and weights are unavailable. Survival information
for the unselected subjects in the representative sample is missing, such that a Cox
model based on the representative sample is inapplicable.
In our analysis of national kidney transplant data, the hazard ratio for ECD (ver-
sus non-ECD) was estimated at 2.20 based on the weighted Cox model and 1.72
based on the unweighted model. Thus, among the deceased-donor organs currently
transplanted, ECD kidneys are associated with a 72% increase in graft failure hazard
relative to non-ECDs. The 72% increase is quite consistent with the results of Port
et al. (2002), from which the ECD definition was derived. The results of Ojo et al.
(2001) indicate that the mortality hazard is lower for patients with an ECD trans-
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plant than those on the waiting list. Moreover, Schaubel, Wolfe & Port (2006) report
that, on average, patients have lower mortality if they accept an ECD compared to
“standard therapy” (foregoing an ECD with the possibility of subsequently receiving
a non-ECD transplant). In the interests of patients, current efforts to further expand
the kidney donor pool by discarding fewer ECDs must be tempered by the fact that
the results of Ojo et al. (2001) and Schaubel, Wolfe & Port (2006) are based not
on ECD kidneys, but on ECDs currently transplanted. In particular, the results
of Schaubel, Wolfe & Port (2006) demonstrate a mortality reduction (ECD versus
standard therapy) which is quite modest and hence could easily be eliminated by
utilizing ECD kidneys with a >2-fold increase in graft failure risk. The difference
between our weighted (reflecting ECDs generally; HR=2.20) and unweighted (re-
flecting ECDs selected for transplantation; HR=1.72) analyses underscore the value
of clinician judgement.
The proposed method should have broad applicability in biomedical research,
particularly observational studies. For example, in liver transplant research, there is
interest in a recently developed Donor Risk Index (DRI) on the survival of recipients
(Feng et al. 2006). In this case, livers with high DRI values have higher probability
of being discarded, which may result in under-estimating the importance of DRI on
post-liver transplant outcomes.
Investigators may raise the question of whether using the weighted version of the
Cox model is required for their particular application. In certain cases, this issue
could be addressed indirectly without fitting the weighted model. That is, if there
are no covariates (not already included in the Cox model) which predict selection
probability, then the unweighted model should generate approximately the same
parameter estimates as the weighted model. However, as our simulation results indi-
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cate, weighting can improve efficiency (using the proposed variance estimator) even
when the selection probability model is mis-specified. Formal tests of the equality of
the weighted and unweighted parameters could prove very useful.
2.7 Appendix





[β′Zi(t) − log{S(0)w (β, θ̂; t)}]wi(θ̂)dNi(t). Setting DwN(β) = N−1{`wN(β̂w) −
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}
dNi(t).
By assumption (d), Xi and Zi are bounded almost surely; the increment dNi(t)
is either zero or one. We restrict attention to β in a compact set, Br = {β :‖
β − β0 ‖≤ r}, with boundary ∂Br = {β :‖ β − β0 ‖= r}. Since θ̂ is the Maximum
Likelihood Estimator (MLE) of θ0, θ̂
a.s.−→ θ0 as N −→ ∞. Therefore, after applying






−Iie−θ′0Xi(β − β0)′Zi(t)dNi(t)X ′i(θ̂ − θ0) + op(1) and converges almost
surely to zero as N −→∞.
Under the assumed conditions,
sup
t∈[0,τ ]
||S(d)w (β, θ; t)− s(d)w (β, θ; t)|| a.s.−→ 0,(2.5)
for d = 0, 1, or 2 and any β in a compact set. Using the strong consistency of θ̂ for
θ0, S
(d)
w (β, θ̂; t)
a.s.−→ s(d)w (β, θ0; t) by the continuous mapping theorem, with s(0)w (β, θ; t)
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bounded away from zero for all β and θ. Applying the continuous mapping theorem,
followed by arguments similar to those used for Dw1:N(β), D
w
3:N(β)




(β−β0)′Zi(t)dNi(t) is bounded. By condition (f), pi(θ0) > 0
and hence wi(θ0) is also bounded. Using the SLLN, D
w
2:N(β)




≡ Dw2 (β). Similarly, Dw4:N(β) a.s.−→ E
[∫ τ
0
wi(θ0) log{s(0)w (β0, θ0; t)/s(0)w (β, θ0; t)}dNi(t)
]
≡
Dw4 (β). Combining results given above regarding D
w
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Since β falls in a compact set, Br, with Br specifically set such that it contains β0,
then DwN(β)
a.s.−→ Dw(β) uniformly on β ∈ Br. In addition, ∂Dw(β)/∂β |β=β0= 0p×1
and ∂2Dw(β)/∂β∂β′ = −Aw(β, θ) is negative definite by condition (e). Therefore,
Dw(β) has a unique maximizer and is maximized at β = β0. Since supβ∈Br |DwN(β)−
Dw(β)| a.s.−→ 0, when N is large enough, DwN(β) will also have a unique maximizer.
Then, given that ∂DwN(β)/∂β|β=β̂w = 0p×1, β̂w is the unique maximizer of DwN(β).
Setting r arbitrarily small, when N −→∞, β̂w a.s.−→ β0.
Proof of Theorem 2. Using a Taylor expansion around β = β0, N
1





2 UwN(β0, θ̂) where β∗ lies between β̂ and β0 in Rp. Using (2.5), the
fact that θ̂





2 (β̂w − β0) = AwN(β0, θ0)−1N−
1
2 UwN(β0, θ̂) + op(1). Through the definition of
S
(d)






wi(θ){Zi(t)− Zw(β, θ; t)}dMi(β, θ; t).
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We set UwN(β, θ) = U
w

















{Zi(t)− Zw(β, θ̂; t)}dMi(β, θ̂; t).
By the continuous mapping theorem and the strong convergence of θ̂ to θ0,
N−
1







wi(θ0){Zi(t)− zw(β0, θ0; t)}dMi(β0, θ0; t) + op(1),








wi(θ0){Zw(β0, θ0; t)− zw(β0, θ0; t)}dMi(β0, θ0; t)
∥∥∥∥∥
P−→ 0p×1,
which can be demonstrated by employing various empirical process results. With re-
spect to Uw2:N(β0), apply the delta method, use (2.5), followed by a Taylor expansion,
N
1
2 (θ̂ − θ0) = B(θ0)−1N− 12 UL(θ0) + op(1),
Since, by the SLLN, B̂(θ)
a.s.−→ B(θ). Using arguments similar to those in the exam-
ination of N−
1
2 Uw1:N(β0), replacing θ̂ with θ0 and Zw(β0, θ̂; t) with zw(β0, θ0; t), then
switching the order of summation,
N−
1







Again combining the SLLN and continuous mapping theorem, Ĝ(β0, θ0)
a.s.−→ G(β0, θ0).










ψwi (β0, θ0) + op(1).
Essentially, UwN(β0, θ̂) behaves asymptotically like the sum of independently and iden-
tically distributed mean-zero random vectors, and by Multivariate Central Limit
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Theorem (van der Vaart, 2000), N−
1
2 UwN(β0, θ̂)
D−→ N(0p×1, Σw(β0, θ0)). Finally,
we combine the asymptotic distribution of UwN(β0, θ̂) and (2.6), through Slutsky’s
Theorem (Sen and Singer, 1993), to complete the proof of Theorem 2.
Proof of Theorem 3. The proof of uniform consistency begins by decomposing
αN(t) = Λ̂
w




0 (β̂w, θ̂; t)− Λ̂w0 (β̂w, θ0; t)
α2:N(t) = Λ̂
w
0 (β̂w, θ0; t)− Λ̂w0 (β0, θ0; t)
α3:N(t) = Λ̂
w
0 (β0, θ0; t)− Λ0(t).

























Under assumptions (a) to (f), Xi, S
(0)
w (β, θ; s), wi(θ) and dNi(s) are all bounded
and S
(0)
w (β, θ; s) is bounded away from 0. Using these results, along with the strong









0 (β∗, θ0; s)(β̂ − β0),
where β∗ lies between β̂ and β0 inRp. Since the quantities Zw(β∗, θ0; s) and dΛw0 (β∗, θ0; s)
are bounded, and since β̂w
a.s.−→ β0, applying the SLLN to α2:N(t), it follows that
| α2:N(t) | a.s.−→ 0.








w (β0, θ0; s)
−1
wi(θ0)dMi(β0, θ0; s). By the Uniform Strong Law of Large
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dMwi (β0, θ0; s)
a.s.−→ 0 for t ∈ [0, τ ].
As N −→ ∞, S(0)w (β0, θ0; s)−→s(0)w (β0, θ0; s) which is bounded away from 0. There-




| Λ̂w0 (β̂w, θ̂; t)− Λ0(t) | a.s.−→ 0.
Proof of Theorem 4. Using the SLLN and the almost sure convergence of b̂(β, θ; s)















w (β, θ; s)
2
}
a.s.−→ k(β, θ; s),
where k(β, θ; s) is as defined in Theorem 4. Then,
N
1
2 α1:N(t) = k
′(β̂w, θ̂; t)N
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0 (β, θ; s)
a.s.−→
h(β, θ; t) as N −→∞. Therefore, it can be shown that
N
1
2 α2:N(t) = h
′(β∗, θ0; t)N
1
2 (θ̂ − θ0) + op(1)



























s(0)w (β0, θ0; s)
−1
wi(θ0)dMi(β0, θ0; s) + op(1).
where the last equality can be shown using the strong convergence of S
(0)
w (β0, θ0; s)
to s
(0)
w (β0, θ0; s), the continuous mapping theorem and the USLLN.
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Combining the above results, N
1
2 αN(t) is the sum of independent identically dis-
tributed mean-zero random variables. When N is large, by Multivariate CLT, the
finite-dimensional distributions of N
1
2 αN(t) converge to those of a zero-mean mul-
tivariate normal with covariance Ω(s, t) = E{φi(β0, θ0; s)φi(β0, θ0; t)}. Through the
monotonicity of the various components of ψi(β0, θ0; t), it can be demonstrated that
the ψi(β0, θ0; t) are manageable (Pollard, 1990) and hence that N
1
2 αN(t) is tight.
Applying the Functional CLT (Pollard, 1990), N
1
2 αN(t) converges weakly to a zero-
mean Gaussian process with covariance function Ω(s, t).
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CHAPTER III
Evaluating Bias Correction in Weighted Proportional
Hazards Regression
Abstract: Often in observational studies of time to an event, the study population
is a biased (i.e., unrepresentative) sample of the target population. In the presence
of biased samples, it is common to weight subjects by the inverse of their respective
selection probabilities. Pan and Schaubel (2007) recently proposed inference proce-
dures for an inverse selection probability weighted (ISPW) Cox model, applicable
when selection probabilities are not treated as fixed but estimated empirically. The
proposed weighted regression parameter estimator is consistent for the target popu-
lation parameter, while the unweighted estimator converges to a modification of the
true value; the modification resulting from the potentially biased sampling mecha-
nism. Similar statements apply to the weighted and unweighted cumulative hazard
estimators. Although parameter estimation is consistent, computation is more in-
tensive than that for an unweighted model. In this article, we propose methods for
evaluating bias in the unweighted partial likelihood and Breslow-Aalen estimators.
Asymptotic properties of the proposed test statistics are derived. The finite-sample
significance level and power are evaluated through simulation. The proposed meth-
ods are then applied to data from a national organ failure registry to evaluate the
bias in a post kidney transplant survival model.
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Key words and phrases: Confidence bands; Inverse-selection-probability weights; Ob-
servational studies; Proportional hazards model; Selection bias; Wald test.
3.1 Introduction
In observational studies of time to an event, we often observe partial information.
That is, some information is unavailable for all subjects sampled from the target pop-
ulation. There are several possibilities for the estimation of covariate effects in this
setting. One method is a complete-case analysis, which assumes that the observed
subjects are a representative sample of the target population; “representative” in the
sense that the relationship of interest is not systematically distorted in the sample
compared to that in the target population. In survival analysis, if there exists some
auxiliary factor which is correlated with the covariate of interest and affects the haz-
ard function and selection probability, the coefficient estimates for the covariate of
interest (i.e., estimated without considering the auxiliary factor) will be systemat-
ically different in the selected sample and target population. Since our goal is to
estimate covariate effects in the target population, estimates obtained based on only
the selected sample are biased. We hereafter refer to a factor inducing such selection
bias as a biasing factor.
We consider the data structure where a potentially biased sample is selected from a
representative sample of the target population. In the presence of a biased sample, an
alternative to a complete-case analysis is to weight each subject by the inverse of their
probability of being selected into the sample, in order to reflect the composition of
the target population. The inverse-selection-probability-weighting (ISPW) method
was originally proposed by Horvitz and Thompson (1952). Binder (1992), Lin (2000)
and Boudreau and Lawless (2006) extended the Horvitz-Thompson method to the
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hazard regression setting in the context of large-scale surveys or designed experi-
ments, where selection probability for each subject is set beforehand and thus can
be treated as known. However, in many practical applications, the probability of be-
ing selected is not known. If appropriate auxiliary data are available (in particular,
pertaining to the biasing factor) for the representative sample, selection probability
may be estimated. Pan and Schaubel (2007) proposed a weighted proportional haz-
ards model with empirical ISPW. Specifically, selection probabilities are estimated
through a logistic model fitted to the representative sample of the underlying tar-
get population, assuming the availability of auxiliary data representing the biasing
factor. Parameter estimators are consistent for their corresponding underlying tar-
get population quantities. In addition, since the estimated weights are, essentially,
trained by the data, efficiency is gained relative to estimators obtained by treating
the weights as if they were known. The elimination of bias and increase in precision
come at the price of more complex modeling, longer computing time and the inability
to use commercially available software packages directly. The methods proposed in
Pan and Schaubel (2007) are necessary if and only if the potential biasing factors
are (i) correlated with the covariate of interest (ii) independently affect the hazard
function (iii) have conditional distributions (given the model covariates) which are
different in the selected sample and target population. In the absence of biased selec-
tion, practitioners would prefer the simpler unweighted method. Whether or not one
employs the weighted method depends on whether the criteria for biased selection
are satisfied and the degree of distortion in the relationships of interest in the biased
sample relative to that in the target population.
No method is currently available to identify cases where the IPSW method is
necessary and, hence, when its advantages outrun the price of computing. In this ar-
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ticle we propose statistics calculated as the scaled difference between the unweighted
and empirically weighted estimates to measure the degree of bias. A Wald-type test
is proposed for the regression parameter, while point-wise and process-based tests
are developed for the cumulative baseline hazard. The unweighted estimators de-
scribe the relationship under study in the possibly biased sample, while the ISPW
counterpart reflects the corresponding relationship applicable to the target popula-
tion. Using the proposed tests, practitioners can make informed choices between the
weighted and unweighted methods using formal procedures.
The proposed tests are motivated by kidney transplant data. At the time of this
report, work is well underway to restructure the kidney allocation system. Currently,
deceased-donor organs are allocated primarily by waiting time. Under a newly pro-
posed allocation system, organs would be allocated based on the difference between
predicted post-transplant and wait-list survival. Hence, there is great need for an
accurate post-transplant survival model. Note, however, that the model will be ap-
plied to wait-listed patients, not transplanted patients. That is, the model will be
used to predict the post-transplant lifetime of a wait-listed patient with a given co-
variate pattern; as opposed to patients with the same covariate pattern who were
already selected (possibly through a biased selection mechanism) for transplanta-
tion. Therefore, the target population includes patients on the wait-list, not patients
already selected off the wait-list to receive a transplant.
Naturally, not all wait-listed patients will receive a transplant. If we desire to
develop a model to apply to wait-listed candidates, post-transplant information is
missing for candidates who were not transplanted. The goal is to estimate the effects
of patient characteristics on the post-transplant hazard. Patients on the kidney wait-
ing list are not randomly selected for transplantation. Although patients on dialysis
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who are not considered suitable candidates for transplantation are simply not placed
on the wait list, the screening process does not end with the decision of whether or
not to wait-list a patient. Certain patients are systematically bypassed on the list
since they are felt to be inferior candidates for kidney transplantation, often due to
the progression of concomitant illnesses which occur or further develop after the time
of wait-listing. Therefore, patients transplanted with a specific covariate pattern are
generally thought not to be representative of patients on the waiting list with the
same covariate pattern. Hospitalization data represent a rich source of auxiliary data
which could potentially account for the residual difference between patients selected
for transplantation and those left on the waiting list. At the Scientific Registry of
Transplant Recipients (SRTR), it is possible to merge the wait-list/transplant data
obtained from the United Network for Organ Sharing (UNOS) and the hospital-
ization data obtained from the Centers for Medicare and Medicaid Services (CMS).
Therefore, we are able to estimate selection probabilities, treating the hospitalization
information as the potential biasing factor. It is important to note that UNOS will
not have real-time access to hospitalization histories, meaning that a post-transplant
survival model which used hospitalization history as covariates would be of no value.
Our objective is to evaluate the degree of bias in a model which is intended to apply to
wait-listed patients but is fitted only to transplanted patients and has no adjustment
for the potentially biased selection. We can fit the estimated ISPW proportional
hazards model of Pan and Schaubel (2007), using hospitalization history to predict
transplant probabilities. The issue of whether or not the weighted model is necessary
will be addressed by our proposed tests.
The remainder of this report is organized as follows. In Section 2, we propose test
statistics for the regression parameter and cumulative baseline hazard and describe
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their asymptotic properties (proved in the Web Appendix). In Section 3, the em-
pirical significance level and power of the proposed test for the regression parameter
are evaluated by simulation studies. In Section 4, each of the proposed procedures
are applied to the kidney transplant data from a national organ failure registry. The
proposed methods are further discussed in Section 5.
3.2 Proposed Methods and Asymptotic Properties
3.2.1 Set-up and Notation
We start by establishing the necessary notation. First, there are N subjects in
the representative sample from the target population. We let Ii (0, 1) be a sampling
indicator; i.e., Ii = 1 if the ith subject is selected from the representative sample into
the possibly biased study sample. In total there are n =
∑N
i=1 Ii subjects selected.
For subject i with event time Ti and censoring time Ci, we define T̃i = min(Ti, Ci),




dNi(t) = Ni(t+dt)−Ni(t), where τ is a prespecified constant satisfying P (T̃i > τ) > 0
and usually set to the end of the study to include all event times. The proportional
hazards model applicable to the target population is as follows,
λiT (t) = λ0T (t)e
β′T Zi(t),(3.1)
where λ0T (t) is an unspecified baseline hazard and Zi(t) is a p× 1 covariate vector.
The proportional hazards model which applies to the selected sample is given by
λiS(t) = λ0S(t)e
β′SZi(t),(3.2)
where λ0S(t) and βS are the possibly biased version of the parameters of interest.
Note that proportionality is assumed for both model (4.1) and model (3.2), but the
constants of proportionality are potentially different, as too are the baseline hazards.
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The hypothesis tests of interest in this report are (i) H0: βT = βS vs H1: βT 6= βS
and (ii) H0: λ0T (t) = λ0S(t) vs H1: λ0T (t) 6= λ0S(t) for t ∈ [0, τ ].









where θ0 is the true parameter vector and Xi is the corresponding q × 1 vector of
predictors. The weight is then given by wi(θ0) = Ii pi(θ0)
−1. Ideally, Xi is the set of
all biasing factors; that is, all factors that are predictive of selection probability and
survival time and correlate with the covariates of interests. If unmeasured biasing
factors exist, consistent estimators of θ0 and hence βT are unobtainable.
3.2.2 Estimation: βS and βT
In addition to the regularity conditions listed in the Web Appendix A, the ISPW
method also assumes that Zi ∪ Xi consists of all factors affecting λiT (t); that is,
the “no-unmeasured-confounders” assumption. In addition, we assume that Ci is









P (t ≤ Ti < t + δ|Ti ≥ t, Zi(t), Xi).
The regression parameter estimator for model (3.2), denoted by β̂S, is the solution







Andersen and Gill (1982) proved that n1/2(β̂S − βS) converges asymptotically to a
zero-mean Gaussian process with covariance consistently estimated by Â(β̂S)
−1. In
addition, the cumulative baseline hazard, Λ0S(t) =
∫ t
0
λ0S(u)du, can be consistently
estimated by the Breslow-Aalen estimator,











The regression parameter estimator for the ISPW proportional hazards model is






wi(θ){Zi(t)− Zw(t; β, θ)} dNi(t).(3.4)
As proved in Pan and Schaubel (2007), the weighted estimator β̂T is strongly consis-
tent for βT , while N
1
2 (β̂T −βT ) follows an asymptotic zero-mean normal distribution












{Zi(t)− Zw(t; β, θ)}⊗2wi(θ)Yi(t)eβ′Zi(t)dΛ̂w0 (t; β, θ)




ψ̂wi (β̂T , θ̂)
⊗2
ψ̂wi (β, θ) =
∫ τ
0
wi(θ){Zi(t)− Zw(t; β, θ)}dM̂i(t; β, θ)− Ĝ(β, θ)B̂(θ)−1ÛLi(θ)
dM̂i(t; β, θ) = dNi(t)− Yi(t)eβ′ZidΛ̂w0 (t; β, θ)













where a⊗2 = aa′.
3.2.3 Test: Regression Parameter
The null hypotheses of interest are that the parameter estimators based on the
potentially biased sampling design have the same limiting value as the corresponding
values in the target population. These two effects will be different and hence the un-
weighted estimator will be biased if and only if the following conditions hold. First,
there exists some biasing factor correlated with the effect of interest and not included
in the proportional hazards model. Second, this factor affects the hazard function.
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Third, the biasing factor affects selection probability. Testing the simultaneous exis-
tence of above three conditions is generally complicated and may in practice be quite





′, where Xi1 is captured by Zi in the fitted






each component of the biasing mechanism, one would test (i) θ01 = 0, (ii) β2 = 0
in the model λi(t) = λ0T (t)e
β′T Zi+β
′
2Xi2 and (iii) test the hypothesis of zero pairwise
association between each element of Zi and each element of Xi2. It is possible that
several of the hypotheses in (i), (ii) or (iii) could be rejected, but that the actual bias
in β̂S is negligible. Conversely, it is also possible that only a small minority of the
hypotheses are rejected, but that bias in at least some elements of β̂S is substantial.
The bottom line is that explicitly testing the conditions under which bias in β̂S can
occur is cumbersome and impractical if even a moderate number of covariates are
involved. Similar arguments could apply to testing H0: Λ0T (t) = Λ0S(t) for t ∈ (0, τ ],
if testing were to proceed through first principles. Moreover, additional steps would
be needed to calculate the overall significance level of the three sets of tests.
Here, we propose a single statistic to examine the degree of bias in β̂S without




where cj is a p× 1 vector with p− 1 elements equal to 0 and the jth element equal
to 1. The quantity Dj reflects the degree of selection bias in the jth element of β̂S.
Typically, the null hypothesis would be given by H0: Dj = 0 with alternative H1:
Dj 6= 0, although a one-sided alternative hypothesis may be indicated depending on
the nature of the specific application. The test statistic is given by D̂2j/V̂ar(D̂j), or by
D̂j/ŜE(D̂j) for single-sided H1. In the remainder of this subsection, we demonstrate
that D̂j/ŜE(D̂j) follows a standard normal distribution asymptotically. As such,
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D̂2j/V̂ar(D̂j) would follow a χ
2
1 distribution as n → ∞. Further, if it was desired to
test two or more elements of βS for bias simultaneously, one could use a modification
of the proposed statistic D = C ′(βT − βS), where C is a p×h matrix of constants
(typically 0’s and 1’s) defined to extract the specific contrasts of interest. Each of
the h columns for C is a vector for one parameter being tested simultaneously. For
example, if we want to test the ith and jth parameter at the same time, C = ci||cj,
where || denotes horizontal concatenation. The test statistics could be given by
D̂′V̂ar(D̂)−1D̂, which follows a χ2h distribution under the null as n →∞.
In order to derive the large-sample properties of D̂, we assume the regularity
conditions listed in the Web Appendix A.
Theorem 1. Under conditions (a) to (f), D̂j is a consistent estimator of D; that is,
D̂j








− 2pc′jA(βS)−1Σβ(βS, βT , θ0)Aw(βT , θ0)−1cj, where p≡E(n/N).
The consistency of D̂j is proved using the consistency of β̂S (Andersen and Gill
1982) and βT (Pan and Schaubel 2007) along with the continuous mapping theorem.
To derive the covariance matrix of n
1




2 (D̂j −Dj) = p 12 N 12 c′j(β̂T − βT )− n
1
2 c′j(β̂S − βS).(3.5)
Note that, because we assume pi(θ) > 0 for i = 1, . . . , N , the average sampling
probability, p, converges to a constant between 0 and 1 and n, N go to∞ at the same
rate. The variances of N
1
2 c′jβ̂T and n
1
2 c′jβ̂S are the same as those of N
1
2 c′j(β̂T−βT ) and
n
1
2 c′j(β̂S − βS), and were derived by Pan and Schaubel (2007), along with consistent
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estimators. The covariance between N
1
2 c′jβ̂T and n
1
2 c′jβ̂S can be written out in terms











2 c′jβ̂T , n
1
2 c′jβ̂S) = p
1
2 c′jA(βS)
−1Σβ(βS, βT , θ0)Aw(βT , θ0)
−1cj,
where
Σβ(β1, β2, θ) = E{ψi(β1)ψwi (β2, θ)′}.
Here, A(βS), A
w(βT , θ0), ψi(βS) and ψ
w
i (βT , θ0) are defined in the calculation of the
covariance matrix of β̂S and β̂T . They can each be estimated by replacing βS, βT ,
Λ0S, Λ0T and θ0 with their sample estimates. The quantity c
′
jΣβ(βS, βT , θ0)cj equals
the covariance between N−
1
2 c′jUw(βT , θ0) and n
− 1
2 c′jU(βS). The (j, k) element in the
matrix Σβ(βS, βT , θ0) is the covariance between the jth element of N
− 1
2 Uw(βT , θ0)
and the kth element of n−
1
2 U(βS). Both the weighted (3.4) and unweighted score
functions (3.3) are zero at the estimated parameter values β̂S, β̂T and θ̂. Furthermore,
when N →∞, each can be written as a sum of independent contributions from each
subject of the selected sample. As such, an estimator of the covariance between the
elements of N−
1
2 Uw(βT , θ0) and the elements of n
− 1
2 U(βS) is the average of the outer
product of the subject-specific contributions to the weighted score (3.4) function and
unweighted score function (3.3). As such, the matrix Σβ(βS, βT , θ0) can hence be
consistently estimated as






i (β̂T , θ̂)
′.
3.2.4 Estimation: Λ0S(t) and Λ0T (t)
Another quality of interest is the baseline hazard function, which is best viewed
as a process over time. We use Λ0T (t) to denote the baseline hazard function in the
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target population, which is consistently estimated by Λ̂w0 (t; β̂T , θ̂), where







w (s; β, θ)
−1
dNi(s). A modified version of Λ0T (t) is
Λ0S(t) with the modification resulting from the potentially biased sampling mecha-
nism.
The unweighted version of the baseline hazard function estimator is Λ̂0(t; β̂S)
where










In the absence of biasing factors, Λ̂0(t)
a.s.−→ Λ0T (t) uniformly in t ∈ [0, τ ] (Fleming
and Harrington, 1991). In the presence of biasing factors, Λ̂0(t)
a.s.−→ Λ0S(t) 6= Λ0T (t).
3.2.5 Test: Cumulative Baseline Hazard
The quantity ∆(t) = Λw0 (t) − Λ0(t) reflects the magnitude of the bias in the un-
weighted baseline hazard function estimator. We summarize the essential asymptotic
properties of an estimator of this quantity, ∆̂(t) = Λ̂w0 (t) − Λ̂0(t), in the following
two theorems.
Theorem 3. Under conditions (a) to (f), ∆̂(t) converges uniformly to ∆(t) as n →∞
for t ∈ [0, τ ].
The consistency of Λ̂0(t; β̂S) to Λ0S(t) for t ∈ (0, τ ] can be demonstrated by
combining the Uniform Strong Law of Large Numbers (USLLN) and the Martin-
gale Central Limit Theorem (Fleming and Harrington 1991). The consistency of
Λ̂w0 (t; β̂T , θ̂) for Λ0T (t) is proved in Pan and Schaubel (2007) through the USLLN
and various empirical process results.
Theorem 4. Under conditions (a) to (f), n
1
2{∆̂(t) − ∆(t)} converges weakly to a
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zero-mean Gaussian process with covariance function:
pE{φwi (s; βT , θ0)φwi (t; βT , θ0)}+ E{φi(s; βS)φi(t; βS)}
− pCov{N 12 Λ̂w0 (s; β̂T , θ̂), n
1
2 Λ̂0(t; β̂S)} − pCov{N 12 Λ̂w0 (t; β̂T , θ̂), n
1
2 Λ̂0(s; β̂S)},
for (s, t) ∈ (0, τ ]× (0, τ ]
Since p = E(n/N), it would be exchangeable if we put N
1
2 as the scale factor
instead of n
1
2 . The proof is similar to that of Theorem 2, in the sense that we
decompose n
1
2{∆̂(t) − ∆(t)} into p 12 N 12{Λ̂w0 (t; β̂T , θ̂) − Λ0T (t)} and n
1
2{Λ̂0(t; β̂S) −
Λ0S(t)}. Through the Martingale Central Limit Theorem (Andersen and Gill 1982,
Fleming and Harrington 1991), we obtain
Cov(n
1
2 Λ̂0(s; β̂S), n
1
2 Λ̂0(t; β̂S)) = E{φi(s; βS)φi(t; βS)},
where
φi(t; β) = −
∫ t
0






w (s; β, θ)
.
It is proved in Pan and Schaubel (2007) that
Cov(N
1
2 Λ̂w0 (s; β̂T , θ̂), N
1
2 Λ̂w0 (t; β̂T , θ̂)) = E{φwi (s; βT , θ0)φwi (t; βT , θ0)}.
The covariance between N
1
2 Λ̂w0 (s; β̂T , θ̂) and n
1
2 Λ̂0(s; β̂S) results from the subject-
specific contributions to each of the weighted and unweighted cumulative baseline
hazard functions such that
Cov(N
1
2 Λ̂w0 (s; β̂T , θ̂), n
1
2 Λ̂0(t; β̂S)) = p
1
2 E{φwi (s; βT , θ0)φi(s; βS)}.
This covariance function can be consistently estimated by replacing all the unknown
quantities by their empirical counterparts.
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To address the question of whether or not the two samples are different in terms
of the baseline hazards at a pre-specified time point, t0, a pointwise confidence in-
terval for ∆(t0) can be calculated using the previously derived variance estimators.
This interval is useful strictly when there are pre-specified time points of particular
clinical interest. Another more general question is whether or not the two baseline
hazard functions are equal over the entire follow up period; i.e., H0 : Λ0T (t) = Λ0S(t)
for t ∈ (0, τ ], implying the construction of a confidence band. Lin, Fleming and
Wei (1994) provide a simulation-based method to estimate a confidence band for
Ŝ0(t; β̂) = exp{−Λ̂0(t; β̂)} based on an unweighted Cox model. We extend this gen-
eral approach to our setting to generate the distribution of δ̂ ≡ supt∈[0,τ ] |n
1
2{∆̂(t)−
∆(t)}Y (t)|. We weight the δ̂ values at each time point by Y (t) = ∑Ni=1 IiYi(t), the
number of subjects at risk. Essentially, a zero-mean Gaussian process with the same
covariance function as n
1
2 ∆̂(t) is simulated to approximate the distribution of n
1
2 ∆̂(t).




2 ψ̂wi (t; β̂T , θ) − n−
1
2 ψ̂i(t; β̂S), the contribution to
n
1
2{∆̂(t)−∆(t)} from each subject, with {(n/N) 12 N− 12 ψ̂wi (t; β̂T , θ)−n−
1
2 ψ̂i(t; β̂S)}Hi,
where Hi (i = 1, · · · , N) are independent standard normal variables. The simu-
lated {(n/N) 12 N− 12 ψ̂wi (t; β̂T , θ)−n−
1
2 ψ̂i(t; β̂S)}Hi are still asymptotically independent
among all subjects. Taking the sum of all subjects at each time point, we obtain
n
1
2{∆̃(t)−∆(t)} = (n/N) 12 N− 12
N∑
i=1






empirically. The aggregate difference in the baseline hazard estimators,
δ̃ = supt∈[0,τ ] |n
1
2{∆̃(t) − ∆(t)}Y (t)|, has the same covariance matrix as the one
proposed for δ̂ on [0, τ ]. The supremum is taken over all time points at which an
event is observed since δ̃ doesn’t change between observed event times. The above
simulation, with different sets of Hi (i = 1, · · · , N), is iterated a large number of
times (e.g. 500). The obtained set of 500 δ̃ values, one from each iteration, form
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an empirical sample of δ̃’s distribution. Finally, an approximate (1 − α) confidence
band for ∆(t) on [0, τ ] is ∆̂(t)±n− 12 q̂α/Y (t), where q̂α denotes the empirical 100(1−
α) quantile satisfying P{δ̃ > q̂α} = α. The applicability of this confidence band
procedure in finite samples has been validated in the unweighted proportional hazards
setting through numerical studies by Lin, Fleming and Wei (1994).
3.3 Simulation Study
We simulated three covariates Zi1, Zi2 and Zi3, where Zi1 is distributed as Bernoulli(0.5),
Zi2 is distributed as N(0, 25) and Zi3 is distributed as Uniform(0, 4). The event time,
Ti, follows an exponential distribution with hazard λi(t) = λ0e
β′0Zi , where λ0 = 0.02
and the vector of coefficients is β′0 = (β1, β2, β3) = (0.5, 0.1, 1.0). The censoring time,
Ci, is uniform on (0, 40) such that the corresponding censoring percentage is approx-
imately 20%. The representative samples (before selection) have sizes ranging from
N = 100 to N = 1000, while the biased samples are created by selecting various
percentages of subjects from the various Zi1 and Zi3 combinations. Specifically, sub-
jects with Zi1 = 0 are always selected; for subjects with Zi1 = 1, probability of being
included in the study sample depends on Zi3 with constant selection probabilities
across [0, 1], (1, 2], (2, 3], (3, 4]. Each data configuration is iterated 1, 000 times.
Our goal is to estimate the regression coefficients when we fit a model with Zi1 and
Zi2 only, such that the Cox model of interest is given by λi(t) = λ0(t)e
β1Zi1+β2Zi2 . The
weights are estimated through the following logistic model, log{pi(θ0)/(1−pi(θ0))} =
θ′0Xi, where Xi = (Zi1, Zi3)
′. Here, Zi3 works as a biasing factor, and the marginal
effects of Zi1 over Zi3 in the target population and in the selected sample will be
different in the presence of biasing factors. Thus, fitting an unweighted Cox model
without Zi3 could potentially introduce bias in estimating the marginal regression
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coefficients for Zi13. The proposed difference D̂1 is calculated by taking difference
between β̂1T and β̂1S from the weighted and unweighted proportional hazards models,
respectively. The variance of D̂1 is estimated using the formula derived in Theorem 3
and the proposed test statistic is computed. The hypothesis H0: βT1 = βS1 is tested
against H1: βT1 6= βS1.
The performance of the D̂ statistic under H0 is evaluated in Table 1. The quantity
E(n) is the expected sample size after selection from the representative sample of size
N . Selection probability is equal across all levels of Zi3. That is, all subjects with
Zi1 = 0 have selection probability of 1; all subjects with Zi1 = 1, regardless of Zi3
values, have selection probability of 0.25 in row 1, 4 and 7; 0.5 in rows 2, 5, 8; 0.75 in
rows 3, 6, 9. Although Zi3 affects λi(t), it is not correlated with the factor of interest,
Zi1, nor does it predict selection probability. Therefore, the regression coefficient,
β1T , from the target population and β1S from the selected sample are equal. For
each data configuration, the unweighted and weighted β1 estimates are obtained,
with their average difference, Ê(D̂1), listed in column 5. We also list the empirical
standard deviation (ESD) of D̂ in column 6. Two sets of variance estimators are
calculated. In column 7 and 8, the estimated weights are inappropriately treated as
fixed. Ignoring the extra variance induced by the estimation of the weights leads to
incorrect asymptotic standard errors (ASE) and empirical significance levels (ESL)
(i.e., artificially low ASEs and high ESLs). In columns 8 and 9, the variance estimator
is based on Theorem 2. The ASEs using our proposed variance estimators are very
close to the corresponding ESDs and the ESLs are always close to the nominal level
of 5%, even when a relatively low percentage of subjects gets sampled.
We also evaluated the power of the proposed test under various departures from
H0: β1T = β1S. We set up different sampling percentages for subjects with different
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wi(θ̂) treated wi(θ̂) treated
as estimated as fixed
row N pi(θ0) E(n) Ê(D̂) ESD ASE ESL ASE ESL
1 100 0.25 62.5 -0.008 0.224 0.201 2.1% 0.112 28.4%
2 0.50 75 0.001 0.119 0.118 3.1% 0.051 38.3%
3 0.75 87.5 -0.003 0.064 0.065 3.4% 0.024 50.2%
4 500 0.25 312.5 -0.003 0.085 0.087 3.6% 0.029 55.3%
5 0.50 375 -0.001 0.047 0.046 4.0% 0.011 66.0%
6 0.75 437.5 0.000 0.026 0.026 4.8% 0.005 77.4%
7 1000 0.25 625 0.000 0.058 0.059 4.3% 0.015 63.5%
8 0.50 750 -0.001 0.032 0.033 4.4% 0.006 72.6%
9 0.75 875 -0.000 0.018 0.019 3.8% 0.002 80.0%
pi(θ0) = P (Ii = 1|Zi1 = 1, Zi3 ∈ (0, 4])
ESD = empirical standard deviation
ASE = average asymptotic standard error
ESL = empirical significance level.
Table 3.1: Simulation Results: Performance of test for regression parameter under the null
Zi3 levels. The power is consistently high (and near 100%) for settings with moderate-
size selected sample. The high power of the test, in part, results from the high
correlation between β̂T and β̂S, since the same data set is used in calculating both
estimators.
An important factor that affects the power of our proposed test is the size of the
selected sample. The power is poor when the representative sample before selection
is small or when the representative sample is moderate-size but the biased sample is
small. Figure 1 shows the power when the expected sample size of the potentially
biased sample increases from 10 to 90 with the same sampling scheme. With mod-
erate sampling probabilities (0.4, 0.2, 0.16, and 0.04 for increasing Zi3 levels), the
power increases from 13.5% with original sample size 100 to 95.7% when the size
before sampling is 500 and plateaus close to 100% thereafter.
Covariate measurement error reduces the power of the proposed test to detect
selection bias, as shown by our simulation results. In the data configuration described
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Figure 3.2: Simulation Results: Effect of measurement error on power of proposed test of H0:
β1T = β1S .
for increasing Zi3 levels), independent Normal(0, 3) random errors are added to some
Zi3 while all Zi3 values with or without errors remain bounded within [0, 4]. When
the percentage of Zi3 with measurement errors increases, the power of our proposed
test drops from 100% to 15.9% (Figure 2).
3.4 Application to Kidney Transplant Data
The target population consists of all patients wait-listed for primary kidney trans-
plantation in the U.S.. Naturally, this hypothetical population is infinite. A repre-
sentative sample was obtained by selecting a cross-section of all patients active on
the wait-list as of January 1, 2000. In total, there were 13, 627 candidates on the
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waiting list that day. Candidates under age 18 are excluded. A five-year time period
(01/01/2000 − 12/31/2004) was chosen over which kidney transplants among the
cross-section subjects were observed. The decision for using a duration of five years
can be justified by the plot of the cumulative incidence of transplantation (Web Fig-
ure 1), treating death and removal from the wait-list as competing risks (Kalbfleisch
and Prentice 2002); Since the curve plateaus after approximately five years. On
December 31, 2004, each patient had potential observation time on wait-list of at
least five years. Those who did not receive a transplant either died or were removed
from the waiting list due to illness or recovery of native renal function. Among the
representative sample of 13, 627 patients, 6, 425 (47%) received a kidney transplant.
The transplanted patients form the selected and potentially biased sample.
Demographic and clinical data on donors and recipients, dates of graft failure
and death where applicable, as well as various clinical measures, were obtained from
the Scientific Registry of Transplant Recipients (SRTR) and collected by the Organ
Procurement and Transplant Network (OPTN). The potential biasing factors under
consideration are represented in aggregate by the hospitalization history. For exam-
ple, it is suspected that patients with fewer hospitalizations are preferred candidates
for kidney transplantation, even after conditioning on all the covariates included in
the proportional hazards model. The frequency and length of hospitalization is also
correlated with many patient comorbidities, as well as the post-transplant mortality
hazard.
Note that adjusting for hospitalization history through covariates in the post-
transplant model is not an attractive option based on practical considerations. Specif-
ically, hospitalization information on transplant candidates will not be available to
UNOS at the time when an organ is to be allocated and hence when candidates
must be ranked. The SRTR has access to both the OPTN (wait-list and transplant)
and CMS (hospitalization history) databases and can link the sources by patient for
those who pay for their health care expenses via Medicare. However, UNOS will not
have access to updated CMS data for the purposes of ranking candidates.
We model the probability of being selected to receive a kidney transplant using
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a binary end point: transplanted within five years (0, 1). Implicitly, we assume that
the θ̂ estimated through this approach converges to the θ0 which governs transplant
probability. In addition to hospitalization frequencies and total days hospitalized,
other covariates adjusted for in the selection probability model include candidate
demographics (gender, age, race), years with end stage renal dialysis (ESRD), vari-
ous disease conditions (drug treated chronic obstructive pulminary disease (COPD),
angina), primary diagnosis at time of listing (polycystic kidneys, diabetes, hyper-
tension), functional status (from fully active daily living to severely disabled), and
various interactions among these covariates. Most terms in the logistic model are
significant predictors of transplant probability at the 0.05 level (Table 2). For each
incidence of hospitalization, the covariate-adjusted odds of getting a transplant drops
4%, while the odds of receiving a transplant drops 1% for each additional day hospi-
talized holding all other factors constant (including number of hospitalizations). Of
the 3, 369 patients with no previous hospitalization, 1, 974 (59%) got transplanted.
In contrast, of the 10, 258 candidates with at least one hospitalization, 4, 451(43%)
got transplants.
For the 6, 425 patients who received a transplant, each recipient was followed until
death, loss to follow up or the conclusion of the observation period (06/30/2006).
Among the 6, 425 transplant recipients, 5, 025 were alive at the end of follow-up,
while 1, 400 (22%) died.
The predicted selection probabilities from the logistic model could get very close
to zero and hence lead to unrealistically large weight values. These large values are
very influential on Var(β̂T ). Bounding weights at an arbitrary upper limit, u, reduces
Var{β̂T (u)} at the price of larger bias. An optimal upper bound for weights should
minimize mean square error (MSE) of β̂T (u), defined as the sum of diag[Var{β̂T (u)}]
and diag[{β̂T (u)− β̂T}⊗2], where diag(A) is a vector consisting of the main diagonal
of A. In our real data analysis, the weights range from 1.21 to 54.22. Web Figure 2
shows the U-shape curve of the MSE for various upper bounds. For our application,
we estimate that the minimum MSE is achieved when weights are bounded at 20.
Both weighted and unweighted proportional hazards models were fitted, adjusting
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Covariate, Xik θ̂k ŜE(θ̂k) p eθ̂k
Hospitalization frequency -0.03 0.008 < 0.0001 0.97
Days hospitalized -0.007 0.001 < 0.0001 0.99
Female -0.30 0.05 < 0.0001 0.74
Age 18 - 24 0.63 0.13 < 0.0001 1.87
Age 25 - 34 0.57 0.07 < 0.0001 1.77
Age 35 - 44 0.27 0.06 < 0.0001 1.31
Age 55 - 64 -0.26 0.05 < 0.0001 0.77
Age 65 - 70 -0.27 0.09 0.0021 0.76
Age ≥ 70 -0.69 0.11 < 0.0001 0.50
African American vs. Caucasian -0.10 0.04 0.02 0.90
COPD -0.35 0.17 0.04 0.70
Angina -0.24 0.06 < 0.0001 0.78
Polycystic kidneys 0.29 0.09 0.0008 1.34
Diabetes -1.17 0.21 < 0.0001 0.31
Hypertension -0.11 0.05 0.02 0.90
Years on ESRD -0.01 0.01 0.17 0.99
Functional status: minor disability -0.16 0.07 0.02 0.85
Female×Hospitalization frequency 0.02 0.01 0.02 1.02
Age 65-70×Hospitalization frequency -0.06 0.02 0.0006 0.94
Age×Diabetes 0.01 0.004 0.0092 1.01
Table 3.2: Analysis of SRTR Data Estimated Regression Parameters from Selection Probability
Model
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for the same set of covariates: expanded criteria donor (ECD), recipients demograph-
ics (age, race, gender), years on ESRD prior to wait-listing, hepatitis C antibody
(HCV) status, Chronic obstructive pulmonary disease (COPD), angina, primary re-
nal diagnosis, functional status, and stay in the intensive care unit (ICU) at the time
of wait-listing. All covariates had significant effects on the post-transplant mortality
hazard.
Table 3 lists the difference between each of the weighted and unweighted regression
coefficient estimates, as well as its corresponding standard error, Chi-square test
statistic, and P-value. For almost all covariates, significant differences between the
weighted and unweighted covariate effects are not detected. Age 35− 44 (compared
to age 45− 54), years on ESRD and COPD (yes vs. no) have significantly different
effects in the representative sample and in the selected sample. The hazard ratio
for COPD is 2.40 in the representative sample and 1.55 in the transplanted sample
(P= 0.008). For each additional year on ESRD, the post-transplant death hazard
increases by a multiplier of 1.03 for the transplanted population and by a multiplier
of 1.05 for the wait-listed population (P= 0.046). The hazard for age group 35− 44
is 0.79 times of that for the reference group 45 − 54 using the weighted estimate,
while the hazard ratio decreases to 0.67 with the unweighted estimate (P= 0.029).
Survival function estimates based on the proportional hazards model are calcu-
lated for both the representative sample and the transplanted sample, as well as
estimated cumulative baseline hazard functions. The weighted and unweighted sur-
vival curves are plotted in Web Figure 3. Both the 95% pointwise confidence interval
and confidence bands of the difference of the two estimated baseline hazards func-
tions are calculated based on results from Theorem 4 and are together in Figure 3.
It is clear from the figure that at most of the 0− 5 year post-transplant time inter-
val, the point estimate of the baseline hazards for the wait-listed patients and that
for the transplanted patients are significantly different on a 0.05 significance level.
However, carrying out joint inference of the process across the follow up period, the
two baseline functions appear not to be different.
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Covariate, Zik β̂T β̂S D̂ ŜE(D̂) Chi-square P-value
Drug-treated-COPD 0.87 0.44 0.43 0.16 6.96 0.008
Years on ESRD 0.05 0.03 0.02 0.01 3.98 0.046
Age 18 to 24 -1.10 -1.13 0.03 0.20 0.02 0.883
Age 25 to 34 -0.56 -0.73 0.16 0.20 0.63 0.426
Age 35 to 44 -0.24 -0.40 0.17 0.08 4.77 0.029
Age 55 to 64 0.51 0.49 0.02 0.05 0.12 0.730
Age 65 to 70 0.71 0.73 -0.02 0.05 0.13 0.721
Age 70 up 1.08 1.01 0.07 0.08 0.69 0.405
HCV Positive 0.25 0.28 -0.02 0.11 0.09 0.770
In ICU 1.42 1.47 -0.05 0.15 0.11 0.737
Female -0.06 -0.07 0.01 0.04 0.06 0.800
Angina 0.37 0.30 0.07 0.06 1.33 0.249
Polycystic kidney -0.40 -0.32 -0.08 0.07 1.49 0.222
Diabetes 0.48 0.52 -0.03 0.04 0.53 0.465
Functional status: minor disability 0.26 0.21 0.05 0.10 0.26 0.613
Table 3.3: Analysis of SRTR Data Tests of Differences between Regression Coefficients estimated
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Figure 3.3: Analysis of SRTR data: Test of H0: Λ0T (t) = Λ0S(t). Middle line: Λ̂0T (t; β̂T , θ̂) −
Λ̂0S(t; β̂S); Outer lines: 95% confidence band.
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3.5 Discussion
Weighted proportional hazards models are an attractive option in survival analysis
targeted at a larger underlying population, for the setting where only a possibly bi-
ased sample is observed. Pan and Schaubel proposed an inverse selection probability
weighting proportional hazards model for the setting wherein sampling probabilities
are unknown. In the presence of biasing factors, the weighted proportional hazards
model with estimated ISPW yields parameter estimators which are consistent and
which have reduced variance relative to those which would be estimated by treating
the weights as fixed. These properties come at the expense of increased complexity
and computing time. To identify cases where ISPW is required for a proportional
hazards model, we propose tests for estimating the bias in the unweighted regres-
sion parameter and cumulative hazard estimators. The asymptotic properties of the
proposed statistics are derived. The finite sample performance of a Wald test based
on the proposed statistic is examined through simulation studies with various data
configurations. In the case of no biasing factors, the empirical significance level is
close to 0.05. In the presence of biasing factors, the proposed test is quite powerful.
In cases where the size of the selected sample is insufficient (e.g., n = 20), the power
drops to very low levels (e.g., 14%). A method for evaluating the difference between
the baseline cumulative hazard functions, for the target population and that for the
selected sample is also proposed, with the pertinent asymptotic distributions derived.
The application of the proposed test is very general. When practitioners encounter
data with potential biasing factors, practitioners would be interested in quantifying
the impact of the weighting on bias reduction. In the absence of such a test, choosing
between the weighted and unweighted methods would be ad-hoc. The proposed
testing methods can be used to formalize the decision to use a weighted or unweighted
hazard regression model. The test proposed in this paper works as a statistical tool
to decide which model (weighted or unweighted) to apply in fitting a proportional
hazards model to a potentially biased sample. Similar tests could be derived for the
data structures considered by Binder (1992), Lin (2000) and Boudreau and Lawless
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(2006).
The proposed procedures are applied to national kidney transplant data, where
hospitalization history represents the potential biasing factor. Age 35 − 44, years
on ESRD and COPD were each found to have significantly different regression co-
efficients for the representative sample of all wait-listed patients and the potentially
biased sample of transplant recipients. The pointwise confidence interval for ∆(t)
deviates from zero at some time points, but the confidence bands obtained by taking
the supremum over all follow up period had the zero-difference line included through-
out, indicating no significant difference. The test of H0: βT = βS is powerful in part
due to the high correlation between β̂T and β̂S. The correlation between Λ̂
w
0 (t; β̂T )
and Λ̂0(t; β̂S) can thus also be expected to be very high and, by extension, ∆̂(t1)
and ∆̂(t2) would be expected to be highly correlated. For this reason, the set of
point-wise confidence intervals could give a misleading representation of the process
{∆̂(t); t ∈ [0, τ ]} since the interpretation of sets of point-wise confidence intervals
makes sense only if ∆̂(t1) is uncorrelated with ∆̂(t2) for t1 6=t2, which is clearly not
the case.
Recently there is great interest in reconstructing the organ allocation system for
various organs, including kidney. A newly proposed criterion by which to rank can-
didates for an available donor kidney is the difference between predicted median life
with a transplant and that without a transplant. It is therefore of great value to
obtain an accurate post-transplant survival model applicable to the patients which
require ranking; namely patients wait-listed for a kidney transplant. An ISPW pro-
portional hazards model results in estimators applicable to all wait-listed patients,
but at the expense of increased computation and complexity. Based on the proposed
test, the unweighted model appears to be sufficient. Among the twenty-one covari-
ates, only three were found to be significantly different: age 35− 44, years on ESRD
and presence of COPD. The majority of wait-listed patients are at least age 45 and
are free of COPD. Moreover, no difference was detected with respect to the target
and sample baseline cumulative hazard function.
The practicality of the proposed ISPW method depends on the availability of
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information from a representative sample of the target population, as well as the
availability of data on the potential biasing factors. Since the statistics, D̂ and ∆̂(t)
are constructed by taking the difference between the ISPW parameter estimators
and their unweighted counterparts, the same restriction applies to the test proposed
in this chapter. If we are unable to fit a model to estimate selection probability,
neither β̂T , D̂ or ∆̂(t) are obtainable. In addition, appropriate upper bound can be
set for the estimated weights, intended to achieve the weighted regression parameter
with minimum MSE.
Although our simulation studies demonstrate high power for the proposed test, we
only detect three covariates with significant differences in our real example of kidney
transplant analysis. There are three possible reasons leading to the low detection
number. First, we examine twenty-one recipient and donor characteristics in total.
If we had information on more covariates affecting the post-transplant mortality
hazard, it is quite possible that we would detect more covariates with significantly
different effects for the representative sample and the transplanted sample. That is,
more complete covariate adjustment may result in increased precision and, hence,
power. Second, although the SRTR is an invaluable source of information on U.S.
kidney transplant patients, covariate measurement error is unavoidable due to inac-
curate recall on the part of the patients supplying the information and/or inaccurate
interpretation or recording of information. From our simulation results (Figure 2),
the power of the proposed tests drops in the presence of measurement error. Further
study taking measurement error into account could be an interesting and valuable
extension of our current work. Finally, the representative sample is assembled by
taking a cross section on a single day, other random sampling methods might be
applied to achieve a larger representative sample and thus a larger selected sample.
With more subjects in our models, the power of the proposed test would increase
and some parameter differences with borderline P-values could attain statistical sig-
nificance (e.g., angina, initial diagnosis as polycystic kidney). Furthermore, if strong
empirical or clinical prior knowledge exists to decide the direction of the difference
between βT and βS, a one-sided test can be used. For example, if the effects of a
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given comorbidity in the wait-listed population is always larger in magnitude than
that in the transplanted population (e.g., since the selection among patients with
the comorbidity is more stringent), then one would employ the one-sided alternative
hypothesis, H1: Dj > 0.
3.6 Acknowledgements
This research was supported in part by National Institutes of Health grant R01
DK-70869 (DES). The authors wish to thank the Scientific Registry of Transplant
Recipients for access to the renal transplant data. They also thank the programmers
and analysts at the University Renal Research and Education Association and the
Kidney Epidemiology and Cost Center for assistance with preparing the analysis files.
The Scientific Registry of Transplant Recipients (SRTR) is funded by contract num-
ber 231-00-0116 from the Health Resources and Services Administration (HRSA),
U.S. Department of Health and Human Services. The views expressed herein are
those of the authors and not necessarily those of the U.S. Government. This study
was approved by HRSA’s SRTR project officer. HRSA has determined that this
study satisfies the criteria for the IRB exemption described in the “Public Benefit
and Service Program” provisions of 45 CFR 46.101(b)(5) and HRSA Circular 03.
3.7 References
Andersen, P. K., & Gill, R. D. (1982). Cox’s regression model for counting
processes: A large sample study. Ann. Statist. 10, 1100-20.
Bilias, Y., Gu, M. & Ying, Z. (1997). Towards a general asymptotic theory for
the Cox model with staggered entry. Ann. Statist. 25, 662-82.
Binder, D. (1992). Fitting Cox’s proportional hazards models from survey data.
Biometrika 79, 139-47.
Boudreau, C. & Lawless, J. F. (2006). Survey analysis based on the proportional
hazards model and survey data. The Canadian Journal of Statistics 34, 203-216.
71
Cox, D. (1975). Partial likelihood. Biometrika 62, 262-76.
Fleming, T. R. & Harrington, D. P. (1991). Counting Processes and Survival
Analysis. New York: Wiley.
Horvitz, D. G. & Thompson, D. J. (1952). A generalization of sampling without
replacement from a finite universe. J. R. Statist. Soc. B 47, 663-85.
Kalbfleisch, J. D & Prentice, R. L. (2002). The Statistical Analysis of Failure
Time Data. Hoboken, NJ: Wiley.
Lin, D. Y. (2000). On fitting Cox’s proportional hazards models to survey data.
Biometrika 87, 37-47.
Lin, D. Y., Fleming, T. R. & Wei, L. J. (1994). Confidence bands for survival
curves under the proportional hazards model. Biometrika 81, 73-81.
Pan, Q. & Schaubel, D. E. (2007). Proportional Hazards Regression Based on Bi-
ased Samples and Estimated Selection Probabilities Conditionally accepted by Cana-
dian Journal of Statistics
Pollard, D. (1990). Empirical Processes: Theory and Applications. Hayward, CA:
Institute of Mathematical Statistics.
van der Vaart, A. W. (2000). Asymptotic Statistics. Melbourne: Cambridge.
van der Vaart, A. W. & Wellner, J. A. (1996). Weak Convergence and Empir-
ical Processes. New York: Springer.
CHAPTER IV
Modeling Additive Treatment Effects on the Recurrent
Event Mean in the Presence of a Terminating Event
Abstract: In this chapter, we study the situation where the event of interest can occur
repeatedly for the same subject (i.e., a recurrent event; e.g., hospitalization) and may
be ended by a terminating event (e.g., death). Methods in the existing literature for
comparing treatment-specific event occurrences in the presence of a terminating event
generally fall into one of two broad categories. Marginal methods compare the mean
number of events, averaging over the survival experience; while conditional methods
compare the conditional recurrent event rate given survival. Often, the difference
between treatment-specific recurrent event means will not be constant over time,
particularly when treatment-specific differences in survival exist. In such cases, it
makes more sense to quantify treatment effect based on differences in the recurrent
event (cumulative) means, as opposed to the (instantaneous) rate. We propose two
methods that compare treatments by separately estimating the survival probabilities
and recurrent event rate given survival, then integrating to get the mean number
of events. Both methods combine an additive model for the conditional recurrent
event rate and a proportional hazards model for the terminating event hazard. The
first method factors out differences in the treatment-specific survival distributions
by employing a common survival distribution (intended to serve as a standard) for
both treatment groups. The second proposed method features treatment-specific
survival distributions and generates an estimated difference in treatment-specific
means. The example which motivates this research is the repeated occurrence of
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hospitalization among kidney transplant recipients, where the effect of Expanded
Criteria Donor (ECD) compared to non-ECD kidney transplantation on the mean
number of hospitalizations is of interest.
Key words and phrases: Additive rates model, Competing risks, Marginal mean,
Proportional hazards model, Recurrent event, Terminating event.
4.1 Introduction
Recurrent events are frequently of interest in clinical and epidemiologic studies.
Examples include repeated infections among HIV patients and multiple hospital-
izations in a health services utilization study. A large variety of semiparametric
recurrent event models exist in the literature. These methods can generally be
classified as intensity models or mean/rate models. Intensity models consider the
instantaneous probability of event occurrence conditional on the event history (e.g.,
Prentice, Williams and Peterson, 1981; Andersen and Gill, 1982), while mean/rate
(the rate being the derivative of mean) models consider the marginal mean number
of events (e.g., Pepe and Cai, 1993; Lawless and Nadeau, 1995; Lin, Wei, Yang and
Ying, 2000). Depending on the assumed form of the covariate effects, recurrent event
models can be classified as multiplicative or additive. Proportional means/rates mod-
els assume covariate effects on a multiplicative scale, while additive models assume
them on an additive scale.
Often in biomedical applications, the recurrent event sequence can be stopped
permanently by a terminating event (e.g., death). Various approaches have been
proposed for modelling recurrent events in the presence of a terminating event (e.g.,
Li and Lagakos, 1997; Cook and Lawless, 1997; Ghosh and Lin, 2000; Ghosh and
Lin, 2002), and this area has attracted much attention recently (e.g., Liu, Wolfe
and Huang, 2004; Huang and Wang, 2004; Ye, Kalbfleisch and Schaubel, 2007).
The existing approaches generally fall into one of three categories. First, there are
methods for modelling the marginal mean number of events (e.g., Ghosh and Lin,
2000; Ghosh and Lin, 2002). In this case, the mean averages over surviving and
deceased subjects. In the second category of methods, one models the conditional
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recurrent event rate given survival. This is among the approaches suggested by Cook
and Lawless (1997), and was mentioned by Lin et al. (2000). This method has been
applied quite frequently (e.g., Schaubel and Cai, 2005). A variation of this approach
employs a latent (frailty) variable (e.g., Liu et al., 2004; Ye et al., 2007), conditional
on which the recurrent and terminal events are assumed independent. The marginal
and conditional methods explicitly acknowledge the fact that subjects no longer
experience recurrent events after death and that time to death may differ between
the treatment and placebo groups. The third approach considers the recurrent events
to be a latent process, unobservable after death (e.g., Ghosh and Lin, 2003; Huang
and Wang, 2004). Unlike the previously described marginal and conditional methods,
the latent process approach does not explicitly acknowledge that a subject can not
experience recurrent events subsequent to experiencing the terminating event.
In the application of the Wei, Lin and Weissfeld (WLW; 1989) model to recur-
rent event data, a separate proportional hazards model is fitted for each recurrent
event number, k (k = 1, · · · , K), with the regression parameters and baseline hazard
being k-specific. Li and Lagakos (1997) applied the WLW method to the recur-
rent/terminal event setting. The authors proposed various methods for handling
death. One procedure treats death as a censoring of the recurrent event sequence,
in which case the estimated intensity function was interpreted as conditional on the
subject being alive. In another scenario, death was treated the same as a recurrent
event; in which case the estimated treatment effects reflect the combined effects on
both the recurrent event and death processes.
Cook and Lawless (1997) also studied the estimation of covariate effects on the
recurrent event process conditional on survival. They modeled the recurrent event
rates and means at time t conditional on either the death time equal time t or the
death time no less than time t. Essentially, the comparison of treatment-specific
recurrent event rates or means at time t considers subsets of subjects alive up to
time t.
Ghosh and Lin (2000) proposed nonparametric tests for treatment-specific differ-
ences with respect to the marginal mean number of recurrent events. The Kaplan-
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Meier estimator for survival probabilities and a Nelson-Aalen estimator of the con-
ditional recurrent event rate function given survival are integrated to calculate the
recurrent event means. Ghosh and Lin (2002) later proposed a semiparametric pro-
portional means model for the marginal cumulative number of recurrent events. The
recurrent event rate after death was still taken to be zero, and the marginal rates in
the outcome are implicitly averaged over the recurrent event rates of living and de-
ceased subjects. The authors modeled the same marginal mean as in Ghosh and Lin
(2000), but allowed for covariate adjustment through a semiparametric proportional
means model.
Often investigators are more interested in the absolute difference between re-
current event means (as opposed to their ratio) which implies an additive model.
Schaubel, Zeng and Cai (2006) extended the method of Lin and Ying (1994) to de-
velop an additive rates model, but it was not designed to handle terminating events.
One could develop an extension of Schaubel et al. (2006) to accommodate termi-
nating events, as did in Ghosh and Lin (2002) for the proportional means setting.
However, treatment-specific differences in mean number of events are often not con-
stant over time, particularly when the treatment-specific survival functions differ.
That is, as follow-up time, t, increases, due to subjects dying, the composition of the
study population will shift and the pattern of the shift will be treatment-specific if
treatment affects survival. Therefore, treatment effects on the recurrent event mean
would not be expected to be constant over time in the presence of treatment effects
on survival. In cases where the treatment effect is not constant over time, the cu-
mulative effect is of much greater interest for patient decision-making at time t = 0
than the instantaneous effect.
In this article, we propose two novel semiparametric methods for comparing
treatment-specific recurrent event mean functions in the presence of a terminating
event. Both methods estimate the treatment effect as a process over time and, in
doing so, assume no functional form for the effect. The proposed methods combine
a proportional hazards model for the terminating event and an additive model for
the conditional recurrent event rate given survival. The first proposed method (here-
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after referred to as Method I) employs a common survival distribution in computing
treatment-specific recurrent event means, such that the treatment-specific differences
in survival are factored out. The second method (Method II) employs treatment-
specific survival functions, with the treatment effects measured by differences in
treatment-specific means.
Under a marginal approach, an increase in the event mean could be due to patients
surviving longer, or could be due to patients experiencing events at an increased rate
while they survive, and there is no convenient way to distinguish these two phenom-
ena. In an attempt to factor out differences in survival, Method I estimates what
the difference in the recurrent event means would be if treatment-specific survival
were equal. It measures treatment effects through a standardized difference in the
marginal recurrent event means. That is, applying a standard survival distribution
to compare treatment-specific expected numbers of recurrent events. The measure
proposed in Method I is a hypothetical quantity. There may be occasions when
investigators are interested in a difference in means which would directly incorpo-
rate (rather than factor out) treatment-specific difference in survival. Motivated by
this consideration, we also propose Method II which features treatment-specific sur-
vival distributions and measures treatment effects through the estimated difference
in treatment-specific marginal recurrent event means.
The remainder of this chapter is organized as follows. Section 4.2 explains how the
proposed measures are estimated. The asymptotic properties of the estimators are
listed in Section 4.3, while Section 4.4 evaluates the performance of the asymptotic
results in moderate size samples. We compare mean numbers of hospitalizations
among kidney transplant recipients using our methods in Section 4.5. A discussion
and some concluding remarks are contained in Section 4.6.
4.2 Proposed Methods
In this section, we describe the proposed methods, after establishing notation and
explaining the data structure of interest.
77
4.2.1 Notation and Set-up
We begin by setting up necessary notation. For the ith subject (i = 1, · · · , n), Zi
and Xi denote the vector of covariates for the terminating event model and recurrent
event model respectively. We set Zi = (Zi1, Z
′
i2)
′, Xi = (Xi1, X ′i2)
′ where Zi1, Xi1
are (1/0) indicators for the treatment/placebo and Zi2 and Xi2 represent adjustment
covariates. Correspondingly, we let β0 = (β01, β
′
02)
′ and θ0 = (θ01, θ′02)
′ represent the
regression coefficients for Zi and Xi. In addition, for convenience we devote the co-
variate vectors for a treated subject by Z1i = (1, Z
′
i2)




for a placebo subject, Z0i = (0, Z
′
i2)
′ and X0i = (0, X
′
i2)
′. We use Di for the time
of the terminating event (e.g., death), and Ci for the censoring time. The counting
process for the terminating event, is represented by NDi (t) = I(Di ≤ t,Di < Ci).
We let Yi(t) = I(Ci ∧ Di ≥ t) be the at risk indicator for subject i at time t, and
set π̂(t) = n−1
∑n
i=1 Yi(t). The number of recurrent events as of time t is repre-
sented by NR∗i (t) =
∫ t
0
dNR∗i (s), where dN
R∗
i (s) = N
R∗
i (s) − NR∗i (s−). In the data
structure under consideration, NR∗i (t) = N
R∗
i (t∧Di); that is, recurrent events can
not occur after death. What we observe is a quantity subject to right censoring,
NRi (t) = N
R
i (t∧Di∧Ci). The outcome being modeled is the mean number of re-
current events E{NR∗i (t)|Zi}, which is the integral of recurrent event rate function
over time E{NR∗i (t)|Zi} =
∫ t
0
E{dNR∗i (t)|Zi}. It should be mentioned that we are
not modeling the recurrent event intensity function, E{dNR∗i (t)|Zi,NR∗i (t)}, where
NR∗i (t) = {NR∗i (s); s ∈ (0, t)}, representing the event history up to time t, an ap-
proach considered for example by Andersen and Gill (1982).
As described in Section 4.1, in the presence of a terminating event, the recurrent
event mean is a function of survival probability and the conditional recurrent event
rate given survival. In estimating the mean function, it is natural to consider these
two entities separately. We denote the conditional recurrent event rate given survival
by
dRi(t) = E{dNR∗i (t) | Di > t}.
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−) = Pr(Di ≥ t). We assume that the terminating event hazard function
follows a proportional hazards model,
dΛi(t) = dΛ(t | Zi) = dΛ0(t)eβ′0Zi ,(4.1)
where dΛ0(t) is the unspecified baseline hazard function and the vector β0 represents
the true value of the regression coefficients. The parameter β0 is estimated by β̂, the















with Z⊗0i = 1, Z
⊗1




i. The Breslow-Aalen baseline hazard
estimator, Λ̂0(t; β̂), is employed, where







The subject-specific survival function is then estimated by
Ŝi(t) = exp{−Λ̂i(t)}.
Both multiplicative and additive models have been used in modeling the recurrent
event mean. For certain outcomes such as costs or number of hospitalizations, inves-
tigators are typically more interested in the absolute (as opposed to relative) dollar
amount or hospital admission numbers. Here we use an additive model to estimate
the recurrent event rates among surviving subjects,
dRi(t) = dR(t | Xi) = dR0(t) + θ′0Xidt,(4.2)
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where dR0(t) is the baseline recurrent event rate function and the vector θ0 represents
the true additive effects of the corresponding covariate vector Xi. Usually, there are
common covariates besides Xi1 and Zi1 affecting both the terminating event hazard
and recurrent event rates. As such, the covariate vectors Zi and Xi usually overlap
and will often be identical. Adapting the model of Schaubel et al. (2006) to the


















Our notation is separately listed in Table 4.1.
4.2.2 Method I: Survival-Adjusted Difference in Means
Of interest in this method is the effect of treatment on the mean number of
recurrent events, factoring out the differences in survival distributions for different
treatment groups. We propose a semiparametric method to estimate the additive
treatment effects on the cumulative number of recurrent events given a standard
survival distribution to be applied to each treatment group. Specifically, the following




S(u−|Zi1 = 0)d{R(u|Xi1 = 1)−R(u|Xi1 = 0)},
In the presence of adjustment covariates, Zi2 and Xi2, it is useful to formulate the
measure as








Function Terminating event Recurrent event
Event time Di -
Censoring time Ci Ci
Risk set indicator Yi(t) = I(Ci ∧Di ≥ t) Yi(t) = I(Ci ∧Di ≥ t)
Counting process for event dNDi (t) dN
R
i (t)
Residual dMDi (t) dM
R
i (t)
Covariate vector Zi Xi
Treatment indicator Zi1 Xi1
Adjusted covariate vector Zi2 Xi2
Regression coefficient vector β0 = (β01, β′02)
′ θ0 = (θ01, θ′02)
′
Regression coefficient for treatment β01 θ01
Regression coefficient for adjusted covariates β02 θ02
Covariate vector, treated subject Z1i = (1, Z
′
i2)




Covariate vector, placebo subject Z0i = (0, Z
′
i2)




Information matrix A(β) B
Baseline hazard/rate dΛ0(t) dR0(t)













Ŝ(u−|Z0i )d{R̂(u|X1i )− R̂(u|X0i )},






θ̂′Xids}. After some reorganization, the proposed estimator reduces to






This measure represents the average difference in the mean number of events between
treatment categories while factoring out differences in treatment-specific survival.
The motivation for the proposed estimator is as follows. Typically, a cumulative
effect measure, such as the mean number of events is more meaningful to investiga-
tors than the effect on an instantaneous quantity such as the rate. This is especially
true if the treatment has a time-dependent effect, which is suspected in the moti-
vating example, to be described in Section 4.5. If we compare the marginal means,
we will not know if an estimated treatment effect is resulting from treatment-specific
differences in the survival distribution, or from treatment-specific differences in the
conditional event rate while subjects survive. For example, the marginal recurrent
event mean could be greater for treated patients than placebo patients because ei-
ther (i) conditional on survival the event rates are equal, but treated subjects live
longer; or (ii) treated and placebo subjects have approximately equal survival, but
dR(t|X1i ) > dR(t|X0i ). If we conduct a fully conditional analysis, then integrate in an
attempt to obtain a cumulative effect measure, R(t) =
∫ t
0
dRi(u) is only interpretable
as the mean number of events in the unrealistic setting where death was impossi-
ble. The integrated conditional rate has no straightforward interpretation. We are
attempting to obtain a meaningful cumulative effect estimator which appropriately
acknowledges the occurrence of death, but is not affected by treatment-specific dif-
ferences in survival. The estimator represents a form of standardization, and the
quantity S(t) is intended to represent the survival “average” or “overall” survival.
In keeping with the standardization in objective, one could replace S(t) with the sur-
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vival for one of the treatment groups since, whatever is used to represent Pr(D > t),
the multiplier of dR(t) will be equal across treatment groups.
The proposed procedure to estimate φ(t) consists of three steps. At the first step,
S(t) is estimated. The Kaplan-Meier estimator could be used, but other possibilities
include Ŝ(t|Zji ) for either j = 0 or j = 1, in which case a proportional hazards model
would be fitted. The second step involves fitting the conditional rate model. We
do not need to estimate dR0(t), only the regression coefficient, θ0, since the baseline
rate cancels out. In the third step, φ(t) is computed as in (4.3).
Note that neither the adjustment covariate effects nor the baseline rate are in-
volved in φ(t). The quantity is the product of the rate model treatment effect and
the placebo group truncated life expectancy (restricted survival time mean). This is
the mean difference in the treatment-specific recurrent events, in the scenario where
the treatment and placebo survival were equal. Ordinarily, the treatment effect is
interpreted as “all other covariates being equal”, while here, the interpretation is “all
other covariates and survival being equal”.
Models for the conditional event rate, dRi(t), and the terminating event hazard,
dΛi(t), assume covariate effects which are constant over time, t. Two points are
important in this regard. First, unlike µi(t), covariate effects on both dRi(t) and
dΛi(t) will often be constant over time in practice. In a sense, it is preferable to
model dRi(t) and dΛi(t) separately, since the quantities are more mechanistic than
a measure which integrates over their product. The model dΛi(t) is a standard
Cox model frequently employed in biomedical studies, while the quantity dRi(t) is
analogous to the cause-specific hazard in competing risk studies. Second, models
(4.1) and (4.2) could always be extended to allow for time-varying effects, and the
procedures proposed in this Chapter would still be applicable.
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4.2.3 Method II: Difference in Treatment-Specific Means
We now propose a treatment effect measure which is the difference in treatment-
specific marginal recurrent event means. The means are given by
µ1(t) = E
[




NRi (t)|Zi1 = 0
]
.
As in method I, we model dRi(t) and dΛi(t) separately and average over the observed
adjustment covariates. From this perspective, it is useful to write the treatment-
specific marginal means as
µj(t) = E
[








for j = 0, 1, where the outer expectation is taken with respect to the distribution of
other adjustment covariates besides the treatment, Zi2. By substituting in survival















Ŝ(r−|Z0i ){dR̂0(r) + X ′i2θ̂2dr}.
The actual treatment effect (as opposed to standardized) on recurrent event numbers
can be measured by
ψ(t) = µ1(t)− µ0(t).
which can be estimated as
ψ̂(t) = µ̂1(t)− µ̂0(t)
for t ∈ (0, τ ] using Ŝ(t|Zi) from the proportional hazards model and dR̂(t|Xi) from
the additive conditional rates model.
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Method I measures the treatment effects on the recurrent event number if the sur-
vival distribution was unaffected by the treatment. Under this hypothetical scenario,
the treatment effect on recurrent events is isolated. Method II estimates the true dif-
ference in treatment-specific means, while incorporating (rather than factoring out)
treatment-specific differences in survival. Thus, ψ(t) combines the actual survival
probabilities and recurrent event rates for the treatment and placebo respectively and
reflects the difference in marginal recurrent event numbers which would be observed
between treatment and placebo patients with the same adjustment covariates.
4.3 Asymptotic Properties
In this section, we describe the essential asymptotic properties of the proposed
estimators. We begin by listing the assumed regularity conditions, for i = 1, . . . , n.
(a) {NR∗i (·), Di, Ci, Zi, Xi} are independent and identically distributed.
(b) E[dNR∗i (t)|Di > t, Ci > t, Xi] = E[dNR∗i (t)|Di > t, Xi].
(c) limδ→0 1δPr{t ≤ Di < t + δ|Di > t, Ci > t, Zi} =
limδ→0 1δPr{t ≤ Di < t + δ|Di > t, Zi}.







dR0(t) < ∞ and NRi (τ) < ∞.
(f) Elements of Zi2 and Xi2 are bounded almost surely.















Item (a) is the basis for Central Limit Theorem and is usually satisfied; an ex-
ception would be clustered data. Conditions (b) and (c) correspond to independent
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censoring assumptions for the recurrent and terminating event processes, respectively.
Item (d) is a standard identifiability condition.
We assume that there are no unmeasured factors which predict both dRi(t) and
dΛi(t). This assumption is stronger than the no-unmeasured confounders assumption
typically applied in regression analysis. We evaluate the impact of violations of the
no-unmeasured-predictors assumption in Section 4.5.
We now describe the essential asymptotic results for the proposed estimators. The
proof of each theorem is outlined in the Appendix.
Theorem 1. Under conditions (a) to (g), φ̂(t) converges almost surely to φ(t) for t ∈
(0, τ ]. The proof of Theorem 1 proceeds through a Taylor Series expansion, followed
by repeated application of the Uniform Strong Law of Large Numbers (USLLN).
Theorem 2. Under conditions (a) to (g), n
1
2{φ̂(t) − φ(t)} is converges weakly to
a zero-mean Gaussian process with covariance function E[γi(s; β0, θ0)γi(t; β0, θ0)],
where
γi(t; β, θ) = γi1(t; β, θ) + γi2(t; β, θ) + γi3(t; β, θ)









{Z0k − z(r; β)}′dΛ0(r)du
]
A(β)−1UDi (β)
γi2(t; β, θ) = E[e(u
−|Z0k)]{B−1URi (θ)}1,1













{Zi − z(t; β)}dMDi (t; β)




s(k)(t; β) = lim
n→∞
S(k)(t; β),




and where {C}1,1 denotes the (1, 1)th element of the matrix C.
The proof is done by decomposing n
1
2{φ̂(t) − φ(t)} into three parts and dealing
with each part separately. Taylor series expansions are applied, along with several
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applications of the Strong Law of Large Numbers (Sen and Singer 1993). Results from
each of the three parts are combined to show that n
1





i=1 γi(t; β0, θ0), which can be shown to converge to a zero-mean
Normal distribution for fixed t by the Central Limit Theorem. A demonstration
of tightness completes the proof of weak convergence using results from empirical
process theory (Pollard, 1990; Van derr Vaart and Wellner, 1996). The covariance
function can be consistently estimated by replacing all limiting quantities with their
empirical counterparts, then averaging across Z12, · · · , Zn2.
Theorem 3. Under conditions (a) to (g), ψ̂ is a consistent estimator of ψ; that is,
ψ̂(t)
a.s.−→ ψ(t) for t ∈ (0, τ ]. The proof is similar to that of Theorem 1, at least with
respect to the major tools, Taylor Series expansions and the USLLN.
Theorem 4. Under conditions (a) to (g), n
1
2 (ψ̂−ψ) converges weakly to a zero-mean
Gaussian process with covariance function E[{ξi1·(s; β0, θ0)−ξi0·(s; β0, θ0)}{ξi1·(t; β0, θ0)−
ξi0·(t; β0, θ0)}], where
ξij·(t; β, θ) = ξi11(t; β, θ) + ξi12(t; β, θ) + ξi13(t; β, θ) + ξi14(t; β, θ)









{Z0k − z(r; β)}′dΛ0(r)dR(u|Xjk)
]
A(β)−1UDi (β)
ξij2(t; β, θ) = E
[∫ t
0
S(u−|Zji ){Xji − x(u)}′du
]
B−1URi (θ)
ξij3(t; β, θ) =
∫ t
0
E{S(u−|Zji )}π(u)−1dMRi (u; θ)






′Zji {µ(t|Zji , Xji )− µ(r|Zji , Xji )}







{Xi − x(u)}dMRi (u; θ)













2{µ̂j(t; β̂, θ̂)− µj(t)} = n 12{µ̂j(t; β̂, θ̂)− µ̂j(t; β0, θ̂)}
+n
1
















{Ŝ(r−; β0|Zji )− S(r−|Zji )}{dR0(r) + θ′0Xji dr}.
for j = 0, 1. The major steps of the proof are then similar to those of the proof of
Theorem 2, although there are several more steps. The ξij·(s; β0, θ0) quantities can be
consistently estimated by replacing all limiting values by their empirical counterparts,
then averaging across i = 1, · · · , n.
4.4 Simulation Study
For each data configuration, we generated n = 200 independent and identically
distributed subjects with both terminating and recurrent events. The terminating
event hazard follows the following proportional hazards model,
dΛ(t | Zi) = dΛ0eβ1Zi1+β2Zi2 ,
where Zi1 (treatment) is distributed as Bernoulli (0.5), the adjustment covariate Zi2
follows a Uniform (0, 10) distribution and λ0 = 0.04. We set the coefficient β1 at 0.5
and 1, to examine scenarios of low or high treatment effect on survival. Censoring
is uniformly distributed on (0, 20) which leads to an average censoring percentage of
approximately 42%. The recurrent events follow a Poisson process, with rate function
dR(t | Xi, Qi) = dR0 + Qidt + θ′Xidt,
where Qi follows a Gamma distribution with mean 0.25 and a variance of 0.5 and 1.
The Qi variate represents a frailty term shared by all the recurrent event times for
the same subject and may be thought of as an unmeasured predictor. Note that the
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assumptions of our proposed methods hold under this set-up. The above model was
simulated by generating gap time between events as:
Ti,j+1 = Ti,j − log(Uij){dR0 + Qi + θ′Xi}−1,
for j = 0, · · · , 50, where Uij ∼ Unif(0, 1), Xi = Zi1 and Ti,0 ≡ 0. We varied the
baseline recurrent event rate from 0.125 to 0.25. The covariate Xi is the same as Zi1
in the proportional hazards model for the terminating event, both representing the
treatment or exposure of interest. The regression coefficient for Xi is set at θ = 0.5.
Table 4.2 lists the performance of our proposed estimators ψ̂(t) and φ̂(t) in eight
scenarios of different β1, V (Qi) and dR0 combinations. The average observed num-
ber of recurrent events per subject ranges from 3.0 to 4.4. Three evenly spaced time
points 5, 10 and 15 are picked to examine the performance of the estimators at early,
middle and late follow-up times. In all the tested conditions, ψ̂(t) and φ̂(t) are very
close to their true values (obtained by numerical integration), and average asymptotic
standard errors (ASE) agree well with empirical standard deviations (ESD). Corre-
spondingly, empirical coverage probabilities (CP) are close to the nominal value of
0.95. Overall, the consistency, asymptotic normality and variance estimator appear
to work very well in moderate size samples.
Next, we evaluated the sensitivity of our proposed methods to the no-unmeasured-
predictors assumption. Specifically, we set up a model with the gamma frailty, Qi,
affecting both dΛi(t) and dRi(t), in violation of our underlying assumptions. The
simulated proportional hazards model (4.1) and the additive recurrent rate model
(4.2) change to
dΛ(t | Zi) = Qieβ′ZidΛ0
dR(t | Xi) = dR0 + (Qi + θ′Xi)dt,
respectively. In addition to the scenarios examined in the simulation study of the
correct model, an extreme case where V (Qi) = 2, which is 8 times E(Qi), was also
examined to assess the impact of highly variable frailty terms on the performance of
ψ̂(t) and φ̂(t).
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Method I: φ̂(t) Method II: ψ̂(t)
β1 V (Qi) dR0 t φ(t) bias ESD ASE CP ψ(t) bias ESD ASE CP
1 0.5 0.25 5 2.12 0.03 0.38 0.38 0.96 1.16 0.02 0.34 0.34 0.95
10 3.64 0.04 0.66 0.65 0.96 1.01 0.05 0.57 0.56 0.95
15 4.73 0.07 0.87 0.85 0.96 0.53 0.06 0.74 0.74 0.95
0.125 5 2.12 -0.00 0.38 0.37 0.95 1.28 0.01 0.34 0.33 0.95
10 3.64 -0.01 0.66 0.64 0.95 1.34 0.02 0.54 0.54 0.95
15 4.73 0.01 0.87 0.84 0.95 1.05 0.04 0.70 0.71 0.95
1 0.25 5 2.12 0.01 0.50 0.48 0.95 1.16 -0.01 0.45 0.43 0.95
10 3.64 0.02 0.87 0.83 0.95 1.01 0.00 0.74 0.710 0.94
15 4.73 0.04 1.14 1.08 0.95 0.53 0.03 0.96 0.91 0.94
0.125 5 2.12 0.04 0.47 0.47 0.96 1.28 0.00 0.44 0.43 0.96
10 3.64 0.06 0.81 0.82 0.95 1.34 0.02 0.71 0.69 0.95
15 4.73 0.09 1.07 1.07 0.96 1.05 0.05 0.89 0.89 0.95
0.5 0.5 0.25 5 2.12 0.00 0.36 0.36 0.96 1.71 -0.02 0.36 0.35 0.96
10 3.64 -0.00 0.61 0.63 0.96 2.42 -0.03 0.62 0.61 0.96
15 4.73 0.01 0.81 0.82 0.96 2.65 -0.03 0.83 0.84 0.97
0.125 5 2.12 0.00 0.35 0.35 0.95 1.76 -0.02 0.33 0.34 0.96
10 3.64 0.00 0.61 0.61 0.94 2.58 -0.04 0.58 0.59 0.96
15 4.73 0.01 0.81 0.80 0.95 2.91 -0.03 0.77 0.80 0.97
1 0.25 5 2.12 -0.00 0.47 0.46 0.96 1.71 0.02 0.47 0.45 0.95
10 3.64 -0.00 0.80 0.79 0.96 2.42 0.03 0.80 0.77 0.95
15 4.73 0.01 1.06 1.03 0.96 2.65 0.05 1.04 1.02 0.95
0.125 5 2.12 -0.00 0.47 0.46 0.96 1.76 -0.03 0.47 0.44 0.95
10 3.64 0.01 0.81 0.78 0.96 2.58 -0.05 0.80 0.75 0.95
15 4.73 0.01 1.06 1.03 0.96 2.91 -0.04 1.05 0.99 0.95
ESD = empirical standard deviation
ASE = average asymptotic standard error
CP = coverage probability.
Table 4.2: Simulation Results: Performance of Proposed Estimators
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Method I: φ̂(t) Method II: ψ̂(t)
V (Qi) β1 dR0 φ(t) bias ESD ASE CP ψ(t) bias ESD ASE CP
2 1 0.25 4.42 -0.04 0.35 0.35 0.93 4.18 0.01 0.39 0.38 0.95
0.125 4.42 -0.06 0.31 0.31 0.95 4.22 0.01 0.33 0.33 0.94
0.5 0.25 4.41 -0.01 0.35 0.35 0.94 4.30 0.00 0.37 0.38 0.94
0.125 4.42 -0.00 0.32 0.31 0.95 4.31 0.01 0.33 0.32 0.94
1 1 0.25 4.09 -0.09 0.35 0.35 0.94 3.65 0.04 0.43 0.41 0.94
0.125 4.08 -0.08 0.32 0.33 0.93 3.71 0.03 0.35 0.34 0.95
0.5 0.25 4.09 -0.06 0.37 0.36 0.94 3.86 0.03 0.41 0.40 0.95
0.125 4.08 -0.03 0.33 0.33 0.95 3.88 0.05 0.34 0.34 0.96
0.5 1 0.25 3.62 -0.11 0.37 0.36 0.93 2.91 0.01 0.44 0.43 0.94
0.125 3.62 -0.12 0.33 0.34 0.93 3.01 0.04 0.37 0.36 0.94
0.5 0.25 3.61 -0.05 0.37 0.36 0.94 3.25 0.01 0.43 0.42 0.94
0.125 3.62 -0.08 0.35 0.34 0.93 3.30 -0.01 0.35 0.35 0.96
Estimators are evaluated at t = 10, the mean of the censoring distribution.
Table 4.3: Simulation Results:Robustness of Proposed Estimators under a Misspecified Model
Table 4.3 demonstrates the robustness of our estimators under this misspecified
model. The estimators are slightly biased, while the proposed robust standard error
estimators are close to the empirical standard deviations and hence coverage proba-
bilities are still close to 0.95. In summary, the proposed methods appear fairly robust
to the no-unmeasured-predictors assumption.
4.5 Application
We applied our two proposed estimators to the study of renal transplant pa-
tients. The goal of our study is to compare the mean number of hospitalizations for
transplant recipients with an Expanded Criteria Donor (ECD) kidney and patients
transplanted with a non-ECD kidney. An ECD is defined as a deceased donor either
(i) age ≥ 60, or (ii) age 50 − 59 and with at least two of the following three char-
acteristics: hypertensive, serum creatinine concentration > 1.5mg/dl, or death due
to stroke (Port et al., 2002). The ECD (0, 1) classification is a well-accepted quality
index for donated kidneys in the nephrology community. In fact, wait-listed patients
willing to accept an ECD kidney are essentially listed separately and generally have
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reduced waiting time until transplant. The relative frequency of ECD transplantation
has increased over time, and several authors have examined the impact of an ECD
on the post-transplant death hazard. Our analysis targets the impact of ECD trans-
plantation on the mean number of post-transplant hospitalizations. Hospitalization
is a composite index of patients’ health status and resource utilization, and therefore
serves as a concrete and objective measure of the post-transplant performance.
Patients began follow-up (t = 0) at the time of kidney transplant. Some received
an ECD transplant, while others got a non-ECD kidney. Patients who receive a kid-
ney transplant are subject to a greatly increased mortality hazard and hospitalization
rate in the weeks immediately following the transplant, due to the risk of surgical
complications, which are suspected to be more serious in ECD recipients. From
a public health perspective, it is of interest to compare ECD and non-ECD trans-
planted patients with respect to mean number of hospitalizations. Due to the strong
time-dependence in the effect of ECD kidney transplantation, the instantaneous ef-
fect on the hospitalization rate is generally of less interest than the cumulative effect.
Moreover, survival probabilities are known to be reduced for ECD relative to non-
ECD recipients (Port et al., 2002). Given these facts, proportionality or additivity
is not expected to hold with respect to the mean function, meaning that estimating
the ECD effect by fitting a multiplicative or additive model to the hospitalization
mean directly would be inappropriate.
The goals of the investigators exemplify some of the limitations in the existing
methods for analyzing recurrent/terminal event data. For example, in comparing
the mean number of events (averaging across the survival experience), it is possible
that non-ECD transplant recipients experience more hospitalizations than ECD pa-
tients simply because they survive much longer than ECD patients. If we were to
compare the conditional hospitalization rate given survival, as did in Schaubel and




dRi(s) can only be interpreted as the mean number of events in the
setting where death were impossible. Using the proposed method, we can obtain the
difference between the number of hospitalizations for ECD and non-ECD recipients
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either considering the true different survival distributions in each type of transplant
or factoring out differences in survival between the two transplant types.
We combine demographic, clinical and mortality data from the Scientific Registry
of Transplant Recipients (SRTR) and hospitalization history information from Cen-
ters for Medicare and Medicaid Services (CMS). The study population is restricted
to patients whose primary payer was Medicare. To increase homogeneity, we also
exclude from our target population repeat and multi-organ transplant recipients.
All Medicare patients age ≥ 18 who received a kidney transplant from a deceased
donor in year 2000 were included in our study sample. In total, 3, 816 recipients
with follow-up and complete covariate information were included and tracked from
the time of transplant until death, loss to follow-up, or at the end of the observation
period (December 31, 2005). Among the 3, 816 patients, 970 (25.42%) were observed
to die during the 6-year follow-up period, with the remaining 2, 846 (74.58%) recipi-
ents censored, either due to loss to follow-up or administratively at 12/31/2005. On
average, each recipient experienced 0.85 hospitalizations during the follow-up period.
As stated, the treatment of interest is donor source: ECD (Zi1 = 1) or non-ECD
(Zi1 = 0). We adjusted the same set of covariates in the proportional hazards and ad-
ditive rates models: candidate demographics (gender, age, race), pre-transplant years
on dialysis, various comorbid conditions (drug treated chronic obstructive pulmonary
disease (COPD), angina, symptomatic cerebral vascular disease, symptomatic pe-
ripheral vascular disease, pretransplant malignancy), primary diagnosis (polycystic
kidney disease, diabetes, hypertension), functional status (fully active to severely
disabled), and stay in the intensive care unit (ICU).
Hazard ratios and recurrent event rate differences for each covariate are listed in
Table 4.4, as well as their corresponding p-values. Recipients of an ECD kidney have
a 1.3 times higher hazard of death compared to non-ECD recipients. At the same
time, ECD kidney recipients experienced 84.4 more hospital admissions per 1,000
patients per year survived. Lower survival probabilities for ECD patients could lead
to a reduced mean number of hospitalizations, since hospitalizations are terminated
by death. However, ECD patients also experience a significantly elevated conditional
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Covariate, Zik = Xik eβ̂k p θ̂k ŜE(θ̂k) p
ECD 1.28 0.002 84.4 29.4 0.004
Female 1.00 0.951 -6.6 19.2 0.732
Age 18 - 24 0.34 0.003 -80.7 41.1 0.045
Age 25 - 34 0.55 0.0001 -87.6 29.0 0.003
Age 35 - 44 0.83 0.092 -56.2 26.4 0.033
Age 45 - 54 1 - 0 - -
Age 55 - 64 1.62 < 0.0001 50.3 28.9 0.082
Age 65 - 70 2.12 < 0.0001 109.5 40.9 0.007
Age ≥ 70 2.88 < 0.0001 146.5 47.8 0.002
African American (vs. Caucasian) 0.99 0.908 5.7 24.3 0.813
COPD 1.25 0.457 7.1 136.5 0.960
Angina 1.40 0.0002 71.1 39.5 0.072
Pretransplant Malignancy 2.67 0.092 750.7 517.9 0.147
Cerebral vascular disease 1.19 0.323 95.4 71.5 0.182
Peripheral vascular disease 1.03 0.848 31.7 56.1 0.571
Polycystic kidneys 0.56 0.0006 -138.7 22.7 < 0.001
Diabetes 1.59 < 0.0001 123.3 32.2 < 0.001
Hypertension 1.19 0.067 16.5 24.3 0.500
Years on dialysis 1.04 0.002 -0.3 3.0 0.932
Functional status: minor disability 0.31 < 0.0001 -114.2 106.3 0.282
Intensive Care Unit 1.24 0.631 -220.1 136.2 0.106
θ: additional hospitalizations per 1,000 per year survived.
Table 4.4: Analysis of SRTR Data Estimated Regression Parameters from Proportional Hazards
and Additive Rates Models
hospitalization rate given survival. The combination of these two effects results in
the marginal effect of ECD on mean hospitalizations.
Based on Method II, ECD recipients on average experience 79 more hospital ad-
missions per 1000 persons compared to a non-ECD recipients regardless the survival
status at the end of one year. This difference increased with more post-transplant
years and reaches 318 per 1, 000 patients at the end of five years. At each time point,
the difference between ECD transplant patients and non-ECD transplant patients is
highly significant. The isolated ECD effect on hospitalization numbers are 81, 158,
233, 304, 372 per 1, 000 patients at the end of one to five years. Take five years
94
Method I Method II
t φ̂(t) ŜE{φ̂(t)} p ψ̂(t) ŜE{ψ̂(t)} p
1 year 0.081 0.028 0.004 0.079 0.028 0.005
2 year 0.158 0.055 0.004 0.153 0.054 0.005
3 year 0.233 0.081 0.004 0.217 0.079 0.006
4 year 0.304 0.106 0.004 0.270 0.104 0.010
5 year 0.372 0.130 0.004 0.318 0.128 0.014
Table 4.5: Analysis of Kidney Transplant Data (ECD vs. non-ECD) Difference in Mean Numbers
of Hospitalizations
as an example, factoring out the differences between ECD and non-ECD survival,
an ECD recipient would experience 0.372 more hospitalizations in five years after
transplant. All the differences at the selected time points are highly significant.
In summary, receiving an ECD kidney leads to significantly higher hospitalizations
post-transplant.
The difference in average hospitalization numbers for an ECD recipient compared
to a non-ECD recipient with the same covariates pattern (i.e., ψ̂(t) ) is plotted in
Figure 4.1. We can see that ECD recipients have more hospitalizations immediately
after transplant. The difference keeps increasing with time and reaches 363 hospital
admissions per 1,000 patients at the end of the 5-year follow-up period. The increase
in hospitalization rate due to ECD dominates the decrease in survival probability
for ECD recipients and leads to positive ECD effects on mean hospitalizations. As
Figures 4.1 and 4.2 illustrate, this positive difference accumulates over time.
It would be possible to set up a procedure to compute 95% confidence bands anal-
ogous to that proposed by Lin, Wei and Fleming (1994). However, due to the number
of patients and event times, such a procedure is computationally inconvenient. As
such, we propose a bootstrap method for calculating simultaneous confidence bands
for the difference ψ over time. First, a bootstrap sample of the same size (n = 3, 816)



























































































































































Difference in Means linear trend
linear trend: The dashed lines in Figure 1-2 represents the difference in means which would result if the difference
across the (0, 400] day interval persisted across the (400, 1825] day interval.



























































































































































Difference in Means linear trend
linear trend: The dashed lines in Figure 1-2 represents the difference in means which would result if the difference
across the (0, 400] day interval persisted across the (400, 1825] day interval.
Figure 4.2: ECD Effects on Mean Number of Hospitalizations - Method II
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culated for each day of the follow-up period because the cumulative hospitalization
rate changes by day and survival probability drops at each death time. Third, find
η = sup(|ψ̃(t) − ψ(t)|). Here, ψ(t) is estimated by ψ̂(t) from the original data set.
Then, the same procedure is repeated for 200 times and an empirical distribution
of the η is obtained. Finally, the 95th quantile of η, q̃0.95, is computed through this
empirical distribution, following which confidence bands are calculated as ψ̂(t)±q̃0.95.
¿From Figure 4.3 and 4.4, confidence bands are wider than the pointwise confi-
dence interval since confidence bands represent the variation of the supremum over
five years of follow up. Also by comparing Figure 4.3 and 4.4, φ̂(t) from Method I
has better precision and narrower confidence bands possibly because estimator φ̂(t)
employs a standard survival distribution, dR̂0(u) and θ̂
′




Ŝ(u; β̂|Z0i )dR̂i(u; θ̂|X1i ) and
∫ t
0
Ŝ(u; β̂|Z0i )dR̂i(u; θ̂|X0i ). The isolated
treatment effect on hospitalization means is highly significant at the end of 1 − 5
years. But the process φ̂(t) is not significantly different from zero in the first 39
months post transplant, and the difference becomes significant after the 39th month.
In Method II, although post-transplant hospitalization means in ECD and non-ECD
transplant patients, µ̂1(t) and µ̂0(t), differ significantly pointwise, the process ψ̂(t) is
not significantly different from zero over five years post transplant.
4.6 Discussion
We propose semiparametric methods to compare marginal treatment-specific mean
number of recurrent events in the presence of a terminating event. The proposed
methods involve modeling terminating event survival probability and the conditional
recurrent event rate given survival separately, then integrating to estimate treatment-
specific marginal recurrent event means. Two different effect measures are proposed,
with their asymptotic properties derived and evaluated in moderate size samples.
We demonstrate that these two estimators work reasonably well under misspecified
models; that is, models failing to incorporate unmeasured predictors of both the
terminating event hazard function and conditional recurrent event rate. Both esti-

























































































































































The two outside lines are 95% confidence bands for the year 0-5 interval.
The five vertical bars represent 95% pointwise confidence intervals at the end of year 1, · · · , 5.
Figure 4.3: 95% Confidence Bands and Pointwise Confidence Intervals for the Difference between
























































































































































The two outside lines are 95% confidence bands for the year 0-5 interval.
The five vertical bars represent 95% pointwise confidence intervals at the end of year 1, · · · , 5.
Figure 4.4: 95% Confidence Bands and Pointwise Confidence Intervals for the Difference between
ECD and non-ECD recipients in Hospitalization Means by Method II
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transplantation on post-transplant hospitalization admission numbers. ECD recipi-
ents are found to have consistently more hospitalizations during the whole follow-up
period, with the difference between ECD and non-ECD recipients increasing with
time.
There are several possible variations to the proposed methods; for example, a
multiplicative recurrent event rate model, or nonparametric estimators for the ter-
minating event survival probabilities. In practice, the appropriateness of the chosen
models depends on the degree to which its assumptions suit the data and its inter-
pretation answers the question of interest. Our choice of the proportional hazards
and additive rates models is a combination of appropriate model and straightforward
interpretation.
Both proposed estimators, φ̂(t) and ψ̂(t), are asymptotically normal, with ex-
plicit variance estimators, and one can construct point-wise confidence intervals and
simultaneous confidence bands for each. However, φ̂(t) and ψ̂(t) have different in-
terpretations and are answering different questions. For investigators interested in
the actual difference between group-specific recurrent event means, ψ̂(t) would be
preferred. On occasions where investigators wish to isolate the treatment effect
on the recurrent events, φ̂(t) provides a standardized difference between treatment-
specific recurrent event means, since it factors out the treatment-specific differences
in survival probabilities. Although such a comparison is hypothetical, standardized
comparisons are widely used, with the common objective of describing a single effect
in a hypothetical setting wherein all other factors are equal.
Our strongest assumption is that there are no unmeasured predictors of both the
terminating event hazard and conditional event rate. In observational settings, this
assumption will fail frequently. Several issues are important in this regard. First, the
unmeasured predictor must be a risk factor for both the terminating and recurrent
event conditional on all measured covariates. If the most important predictors are in-
cluded in the adjustment covariate vector, bias may be minimized and the estimated
treatment effect may be a good approximation to the reality. Second, the most pop-
ular alternative to a no-unmeasured-predictor assumption is to incorporate a frailty.
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However, most frailty approaches for recurrent event data employed assume that the
events follow a Poisson process, which is restrictive in its own right. To the best of
our knowledge, there is only one method (Ye, Kalbfleisch and Schaubel; unpublished
manuscript) which employs a frailty in the absence of the Poisson-process assump-
tion, and that method does not propose cumulative effect measures. Third, our
sensitivity analysis reveals that if an unmeasured frailty affects both the terminating
event hazard and conditional rate, bias is quite low.
4.7 Appendix
Proof of Theorem 1 : Under conditions (a) to (g), we have essentially the same
framework as the additive rates model of Schaubel et al. (2006), with the at risk
indicators redefined. As such, the almost sure convergence of θ̂ to θ0 holds from
Theorem 2 of Schaubel et al. (2006). Therefore, by the Cramer-Wold Theorem (Sen
and Singer, 1993), the first element of θ̂, denoted by θ̂1, is a consistent estimator for
θ01.
Since β̂
a.s.−→ β0 and Λ̂0(t) a.s.−→ Λ0(t) for all t ∈ (0, τ ] (Andersen and Gill, 1982), by
the continuous mapping theorem, Ŝ(u−|Zi) a.s.−→ S(u−|Zi) and hence φ̂(t; θ̂, β̂) a.s.−→
φ̂(t; θ0, β0). Finally, the empirical average taken in φ̂(t) converges to its expectation
for t ∈ (0, τ ] by the Uniform Strong Law of Large Numbers (USLLN; Pollard, 1990).
Proof of Theorem 2 : We can decompose n
1




2{φ̂(t; β̂, θ̂)− φ(t)} = n 12{φ̂(t; β̂, θ̂)− φ̂(t; β0, θ̂)}
+n
1
2{φ̂(t; β0, θ̂)− φ̂(t; β0, θ0)}
+n
1
2{φ̂(t; β0, θ0)− φ0(t)}.(4.4)
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For the first part of (4.4), applying a Taylor expansion around β0, we get
n
1























2 (β̂ − β0)du(4.5)








as n →∞. Combining (4.5) and (4.6),
n
1





For the second term of (4.4),
n
1







2 (θ̂1 − θ01).
The difference between θ̂ and θ0 can be expressed as sum of independent identical
contributions from each subject (Schaubel et al. 2006). When n →∞ ,
n
1






2 (θ̂1 − θ01) corresponds to the first element of n 12 (θ̂ − θ0); that is,
n
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Combining (4.8) and (4.9), we get
n
1






For the third term of (4.4), as n →∞ ,
n
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−1 − s(0)(r; β0)−1]dMDi (r; β0).
The second term in the summation converges to zero, which can be shown by the
strong convergence of S(0)(r; β0) to s













In summary, combining (4.7), (4.10) and (4.11)
n
1

















as n →∞ , such that
n
1




as n →∞ , and hence n 12{φ̂(t; β̂, θ̂)−φ0(t)} behaves asymptotically as a scaled sum
of independent and identically distributed zero mean variables.
The quantity γi(t; β0, θ0) can shown asymptotically to be martingale (Fleming




i=1 γi(t; β0, θ0) is tight, which combined
with the normality results completes the weak convergence proof. The covariance
function for n
1
2{φ̂(t; β̂, θ̂)−φ(t)}, Φ(s, t) = E[γi(s; β0, θ0)γi(t; β0, θ0)], can be obtained
through the Multivariate Central Limit Theorem (Sen and Singer 1993), and can be
consistently estimated by
Φ̂(s, t) = n−1
n∑
i=1
γ̂i(s; β̂, θ̂)γ̂i(t; β̂, θ̂).
Proof of Theorem 3 :
We prove the consistency of µ̂1(t; β̂, θ̂) and µ̂0(t; β̂, θ̂) separately, following which
the consistency of ψ̂(t; β̂, θ̂) is directly obtained.







[Ŝ(r−|Z1i ){dR̂0(r) + (θ̂1 + X ′i2θ̂2)dr}
−Ŝ(r−|Z0i ){dR̂0(r) + X ′i2θ̂2dr}].
As stated in the proof of Theorem 1, θ̂
a.s.−→ θ0, β̂ a.s.−→ β0, Λ̂0(t) a.s.−→ Λ0(t), and
Ŝ(u−|Zi) a.s.−→ S(u−|Zi), for all t ∈ (0, τ ]. Therefore, by the Continuous Mapping
Theorem,
µ̂1(t; θ̂, β̂)
a.s.−→ µ̂1(t; θ0, β0),
for all t ∈ (0, τ ].
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Finally, applying the USLLN (Pollard, 1990) to µ̂1(t; θ0, β0) = n
−1 ∑n
i=1 µ1(t; θ0, β0|Zi, Xi),
we obtain n−1
∑n
i=1 µ1(t; θ0, β0|Zi, Xi)
a.s.−→ E{µ1(t; θ0, β0|Zi, Xi)}, which is essen-
tially µ1(t). Similar arguments can be applied to µ̂0(t; θ̂, β̂).
Proof of Theorem 4 :
We describe here the distribution of n
1
2{µ̂1(t; β̂, θ̂)−µ1(t)}. A similar development
applies to n
1
2{µ̂0(t; β̂, θ̂) − µ0(t)}. First, n 12{µ̂1(t; β̂, θ̂) − µ1(t)} is decomposed into
four parts as follows:
n
1
2{µ̂1(t; β̂, θ̂)− µ1(t)} = n 12{µ̂1(t; β̂, θ̂)− µ̂1(t; β0, θ̂)}
+n
1


















{Ŝ(r−; β0|Z1i )− S(r−|Z1i )}{dR0(r) + θ′0Xji dr}.(4.12)
For the first part of (4.12) , we apply a Taylor expansion around β0 to obtain
n
1











2 (β̂ − β0)







{exp{−eβ∗′Z1i Λ̂0(r) + β∗′Z1i }Z1i Λ̂0(r)
























2 (β̂ − β0),










For the second part of (4.12), when n →∞ ,
n
1

































by the USLLN and the results of Schaubel et al. (2006) for θ̂.
























For the fourth part of (4.12), when n →∞ ,
n
1







2{Ŝ(u−; β0|Z1i )− Si(u−|Z1i )}








2 [exp{−Λ̂0(u; β0)eβ′0Z0i } − exp{−Λ0(u)eβ′0Z0i }]






exp{−Λ0(u)eβ′0Z0i }(eβ′0Z0i )n 12{Λ̂0(u; β0)− Λ0(u)}































2{Λ̂0(u; β0)− Λ0(u)} is derived in (4.11).
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In summary, combining (4.13), (4.14), (4.15) and (4.16), when n →∞ ,
n
1














































2{µ̂1(t; β̂, θ̂)−µ1(t)} is asymptotically n− 12 times sum of independent
and identically distributed terms. The tightness of n
1
2{µ̂1(t; β̂, θ̂) − µ1(t)} can be
proved by examining each component of µ̂1(t; β̂, θ̂) so that n
1
2{µ̂1(t; β̂, θ̂) − µ1(t)}
can be written as sum of monotone bounded functions. Through similar proofs,
n
1
2{µ̂1(t; β̂, θ̂) − µ1(t)} can be written as scaled sum of contributions from each of
the independent and identically distributed subject. After expressing the difference,
n
1
2{µ̂1(t; β̂, θ̂)−µ1(t)}−n 12{µ̂0(t; β̂, θ̂)−µ0(t)}, at the subject level, weak convergence
to a Gaussian process follows from the application of various tools from empirical
process theory (Pollard, 1990; Van der Vaart and Wellner, 1996). The covariance
function for n
1
2{µ̂1(t; β̂, θ̂)− µ̂0(t; β̂, θ̂)} is given by
Φ(s, t) = E[{ξi1·(s; β0, θ0)− ξi0·(s; β0, θ0)}{ξi1·(t; β0, θ0)− ξi0·(t; β0, θ0)}],
which can be estimated by replacing limiting values with their empirical counterparts,
then averaging over the sample.
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CHAPTER V
Conclusion
This dissertation proposes three novel survival analysis methods for use in ob-
servational studies, each motivated by real problems in applying the classic survival
analysis techniques. A common aspect of the three papers is that they were mo-
tivated by specific needs in applying statistical models to real research questions.
Hence, the contribution of this research are of clinical, in addition to biostatistical,
significance. Specifically, Chapter 2 addresses the problem of fitting a proportional
hazards model when subjects have different probabilities of being sampled/observed.
Chapter 3 proposes testing procedures with considerable statistical power to formally
evaluate the degree of selection bias. Chapter 4 considers estimating the treatment
effect on the recurrent event mean, in the presence of a terminating event.
Chapters 2 and 3 feature the idea of “inverse-selection-probability-weighting”, in
which each subject is weighted by the inverse of their selection probability. Under
this approach, inference is valid for the target population before selection. Chapter
3 proposes, as a test statistic, the difference between parameters before and after
selection. Chapter 4 starts from the idea of separately estimating the terminating
event survival probability and recurrent event conditional rate given survival. A
proportional hazards model and an additive rates model are fitted. When we inte-
grate the estimated survival probability and conditional recurrent event rate, we can
choose either a “standard” survival distribution for both groups, or the treatment-
specific survival distribution for the corresponding group. The choice between the




As stated in the beginning of this chapter, each method proposed in this disser-
tation was applied to address an existing medical research question. In Chapter 2,
we determined that Expanded Criteria Donor (ECD) kidneys are associated with a
much higher increase in transplant failure when inference pertains to all procured
kidneys instead of all transplanted kidneys. Inference applicable to all procured kid-
neys has more relevance since wait-listed patients are offered procured kidneys, not
kidneys already transplanted. Previous results based on only transplanted kidneys
underestimate the ECD effect. In Chapter 3, we are interested in the effect of wait-
listed patients’ characteristics on post transplant survival for the purpose of ranking
candidates by predicted “survival benefit”. Selection bias occurs since transplanted
patients are not a representative sample of all wait listed patients, for whom we want
to make inference. The potential biasing factor, morbidity history, could not be ad-
justed at time of ranking. Through the proposed test statistic, chronic obstructive
pulmonary disease (COPD), age 35 to 44 and years on dialysis have significantly dif-
ferent impact on post transplant survival in the transplant candidate and recipient
populations. Chapter 4 continues our interest in ECD transplantation. It is discov-
ered that ECD transplant recipients have higher post-transplant death hazard and
that patients have a higher hospitalization rate while they survive. Overall, ECD
patients have more hospitalizations, despite the fact that they also have significantly
lower survival than non-ECD transplant recipients over the whole post-transplant
follow-up period. Each of these findings is important information for kidney trans-
plantation surgeons and patients, as well as policy makers, in addressing questions
such as how restrictive patients should be with respect to accepting lower quality
organs.
CHAPTER VI
Supplementary Materials for “Evaluating Bias Correction in
Weighted Proportional Hazards Regression”
6.1 Appendix A
We assume the following regularity conditions:
(a) {Ti, Ci, Zi, Ii, Xi} are independent and identically distributed for i = 1, . . . , N .




λ0S(t)dt < ∞ and
∫ τ
0
λ0T (t)dt < ∞.
(d) |Xik| < ∞; |Zik(0)| +
∫ τ
0
|Zik(s)|ds < ∞ almost surely, where the second sub-
script refers to vector element.
(e) Positive-definiteness of the matrices, A(β0), A
w(β0, θ0) and B(θ0), where, for















s(k)(t; β) = lim
N→∞






and for the quantities applicable to the target population,
Aw(β, θ) = E
[∫ τ
0
{Zi(t)− zw(β, θ; t)}⊗2wi(θ)Yi(t)eβ′Zi(t)λ0T (t)dt
]






⊗k, k = 0, 1, 2
Zw(t; β, θ) =
S
(1)
w (t; β, θ)
S
(0)
w (t; β, θ)
s(k)w (t; β, θ) = lim
N→∞
S(k)w (t; β, θ), k = 0, 1, 2
zw(t; β, θ) =
s
(1)
w (t; β, θ)
s
(0)
w (t; β, θ)
B(θ) = E[Xipi(θ){1− pi(θ)}X ′i]
with a⊗0 = 1, a⊗1 = a and a⊗2 = aa′.
(f) There exists a δ such that pi(θ) > δ > 0 almost surely.
6.2 Appendix B
Proof of Theorem 1 : The strong consistency of β̂S was demonstrated by Andersen
and Gill (1982).
The consistency of the weighted parameter estimate, β̂T , for the true parameter
values applicable to the target population, βT , is proved in Theorem 1 of Pan and
Schaubel (2007).
Combining these two results, as a linear combination of the difference of β̂S and
β̂T , D̂j
a.s.−→ Dj by the continuous mapping theorem.
Through a Taylor expansion around β = βS,





























since U(β̂S) = 0. Under the assumed conditions,
sup
t∈[0,τ ]
||S(d)(t; β)− s(d)(t; β)|| a.s.−→ 0,
for d = 0, 1, or 2 and any β in a compact set. Since β̂S
a.s.−→ βS and ‖ β∗ − βS ‖≤
‖ β̂S − βS ‖, β∗S a.s.−→ βS. Using the continuous mapping theorem, S(d)(t; β∗S) a.s.−→
s(d)(t; βS), with s
(0)(t; β) bounded away from zero for all β and t ∈ [0, τ ]. Using
the almost sure convergence of S(d)(t; β∗S) to s






− Z(t; β∗S)⊗2 −→
s(2)(t; βS)
s(0)(t; βS)
− z(t; βS)⊗2 ≡ v(t; βS)








, as defined in condition (e). Hence
n
1
2 (β̂S − βS) = A(βS)−1n− 12 UN(βS) + op(1).(6.1)






Ii[Zi(t)− Z(t; β)]dMi(t; β).
Furthermore, we can write
n−
1

















Ii[Zw(t; βS)− z(t; βS)]dMi(t; βS)
∥∥∥∥∥
P−→ 0p×1.
which can be demonstrated by employing various empirical process results (van der
Vaart 2000) and results from empirical process theory (Pollard 1990, van der Vaart
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1996, Bilias, Gu and Ying 1997). Combining (6.1) and (6.2), we get
n
1






Pan and Schaubel (2007) demonstrated that
N
1
2 (β̂T − βT ) = Aw(βT , θ0)−1N− 12
N∑
i=1
ψwi (βT , θ0) + op(1),(6.4)
where
ψwi (β, θ) =
∫ τ
0
wi(θ){Zi(t)− zw(t; β, θ)}dMi(t)−G(β, θ)B(θ)−1ULi
G(β, θ) = E
[∫ τ
0




ULi(θ) = Xi{Ii − pi(θ)}.
Combining (6.3) and (6.4),
n
1






































2 (D̂ −D)) = Var(D1) + Var(D2)− 2Cov(D1, D2).(6.5)
For D1, p
1
2 converges to a constant between 0 and 1, indicator vector cj is pre-
specified and the asymptotic information matrix for the weighted Cox regression
Aw(βT , θ0)
−1 is also fixed. Hence the variance of D1 is the product of several constants






i (βT , θ0), namely Σw(βT , θ0) = E{ψwi (βT , θ0)⊗2},






−1Σw(βT , θ0)Aw(βT , θ0)
−1cj.(6.6)
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Similar arguments can be applied to Var(D2). The matrix A(βS) is the limiting








Iiψi(βS) can be derived through the Martingale Central Limit Theorem






In terms of Cov(D1, D2), the quantities cj, A
w(βT , θ0)
−1 and A(βS) are fixed.














sider the three possible scenarios for the combination of subject i and j. If i 6= j,
Cov{ψwi (βT , θ0), Ijψj(βS)} = Cov(ψwj (βT , θ0), Iiψi(βS)) = 0 since subjects are all
independent from each other. If i = j and Ii = 0, Cov(ψ
w
i (βT , θ0), Ijψj(βS)) =
Cov(ψwi (βT , θ0), 0) = 0 because subject i does not contribute to the estimation of
βS. If i = j and Ii 6= 0, Cov{ψwi (βT , θ0), Ijψj(βS)} = E{ψi(βS)ψwi (βT , θ0)′} because
both ψi(βS) and ψ
w




















2 nΣβ(βS, βT , θ0)
where
Σβ(β1, β2, θ) = E{ψi(β1)ψwi (β2, θ)′}.
Combining the above results, we obtain
Cov(D1, D2) = p
1
2 c′jA(βS)
−1Σβ(βS, βT , θ0)Aw(βT , θ0)
−1cj.(6.8)
Combining (6.5), (6.6), (6.7) and (6.8), the variance of n
1
2 (D̂ −D) in Theorem 1 is
proved.
6.3 Appendix C
Proof of Theorem 2 : The proof of uniform consistency of of Λ̂0(t; β̂S) to Λ0S(t) for
t ∈ (0, τ ] begins by decomposing α(t) = Λ̂0(t; β̂S) − Λ0S(t) into two parts, α(t) =
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α1(t) + α2(t) with
α1(t) = Λ̂0(t; β̂S)− Λ̂0(t; βS)
α2(t) = Λ̂0(t; βS)− Λ0S(t)





























(s; β∗)dΛ̂0(s; β∗)(β̂S − βS),
where β∗ lies between β̂S and βS in Rp. Since the quantities Z(s; β∗) and dΛ̂0(s; β∗)
are bounded, along with β̂S
a.s.−→ βS, | α1(t) | a.s.−→ 0.
















0 for t ∈ [0, τ ]. As n −→∞, S(0)(s; βS)−→s(0)(s; βS) which is bounded away from 0.
Therefore, | α2(t) | a.s.−→ 0.
Combining results for α1(t) and α2(t) and the triangle inequality,
sup
t∈[0,τ ]
| α(t) | ≤ sup
t∈[0,τ ]
| α1(t) | + sup
t∈[0,τ ]
| α2(t) |,
yields the required result,
sup
t∈[0,τ ]
| Λ̂0(t; β̂S)− Λ0S(t) | a.s.−→ 0.(6.9)
Combining (6.9) and the convergence of Λ̂w0 (t; β̂T , θ̂) for Λ0T (t) (Pan and Schaubel
2007), ∆̂(t; β̂S, β̂T , θ̂) converges uniformly to ∆(t) for t ∈ [0, τ ] by continuous mapping
theorem.
6.4 Appendix D
Proof of Theorem 3 : First, we decompose
n
1













φwi (t; βT , θ0) + op(1),
where
b(t; β, θ) = E{Xie−θ′XiYi(t)eβ′Zi(t)}














w (s; β, θ)
2 dNi(s)
}




φwi (t; β, θ) = k






w (s; β, θ)
.






Iiφi(t; βS) + op(1),
where
φi(t; β) = −
∫ t
0






w (s; β, θ)
.
Asymptotic normality extends to any finite set of time points. Finally, weak
convergence to a Gaussian process follows from the tightness of n
1
2{∆̂(t) − ∆(t)},
which follows from the manageability of both φwi (t; βT , θ0) and φi(t; βS). See Pan
and Schaubel (2007) for pertinent details. For two time points (s, t) ∈ (0, τ ]× (0, τ ],
Cov(n
1
2{∆̂(s; β̂S, β̂T , θ̂)−∆(t)}, n 12{∆̂(t; β̂S, β̂T , θ̂)−∆(t)})
= Cov(∆1(s), ∆1(t)) + Cov(∆2(s), ∆2(t))− Cov(∆1(s), ∆2(t))− Cov(∆2(s), ∆1(t))
where
Cov(∆1(s), ∆1(t)) = pE{φwi (s; βT , θ0)φwi (t; βT , θ0))}
Cov(∆2(s), ∆2(t)) = E{φi(s; βS)φi(t; βS)}
Cov(∆1(s), ∆2(t)) = pE{φwi (s; βT , θ0)φi(t; βS)}
Cov(∆2(s), ∆1(t)) = pE{φi(s; βS)φwi (t; βT , θ0)}.


























































































































Figure 6.2: Analysis of SRTR data: Effect of bounding wi(θ̂) on MSE{β̂T (u)}, where MSE=mean


































































































Figure 6.3: Analysis of SRTR data: Plot of estimated survival functions, exp{−Λ̂0T (t; β̂T , θ̂)} (solid
line) and exp{−Λ̂0S(t; β̂S)} (dotted line).
